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TDP-43 aggregation is the pathological hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal
lobar degeneration with ubiquitinated inclusions (FTLD-TDP). To define pathways important in TDP-43
proteinopathy, a genetic screen for modifiers of TDP-43-mediated eye degeneration was conducted in the
fruit fly (Drosophila melanogaster). This approach and the following studies in the fly identified
transcriptional elongation factor Ell as a potent dose-dependent modifier. Ell is a shared component of little
elongation complex (LEC) and super elongation complex (SEC). Our studies show that downregulation of
additional components in LEC or SEC partially but consistently ameliorates TDP-43-associated eye
degeneration, implicating both Ell-associated complexes in TDP-43 toxicity. LEC regulates transcription of
RNA Polymerase II (Pol II)-transcribed small nuclear RNAs (snRNAs), while SEC mainly regulates
transcription of select inducible genes harboring paused Pol II including stress-induced loci. We hypothesized
that, in the disease state, TDP-43 increases the activity of LEC and SEC, leading to enhanced expression of
select target genes that contribute to neurodegeneration. Our results support this hypothesis by showing that
select targets of LEC and SEC become upregulated in fly heads expressing TDP-43 compared to controls.
Among upregulated targets, U12 snRNA and a stress-induced long non-coding RNA (lncRNA) Hsr were
shown to functionally contribute to TDP-43-induced degeneration in Drosophila. The increase in U12
snRNA leads to elevated activity of the U12-dependent spliceosome, assessed by examining U12-dependent
splicing events. Among the known U12 targets, the splicing of genes CG15735, CG16941 and CG11839 were
shown to be upregulated selectively by TDP-43. In addition, the novel target of TDP-43 Hsr was identified
by polytene chromosome association of TDP-43 and SEC components Lilli and Ell in the fly. We extended
the findings of Hsr to show that the human orthologue Satellite III repeat (Sat III) is elevated in both a
human cellular disease model of TDP-43 toxicity, and FTLD-TDP patient tissue. Furthermore, TDP-43 was
shown to interact with human ELL2 by co-immunoprecipitation from human HEK293 cells. These findings
support a model whereby TDP-43 promotes the LEC and SEC activities through an interaction with ELL2,
leading to abnormal activation of LEC and SEC target genes that contribute to degeneration. These studies
reveal the critical roles of Ell and Ell-associated complexes in TDP-43 toxicity, identify important downstream
targets, and provide potential therapeutic strategies to combat TDP-43-associated neurodegeneration.
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ABSTRACT 
 
LITTLE ELONGATION COMPLEX (LEC) AND SUPER ELONGATION COMPLEX 
(SEC) AS REGULATORS OF TDP-43-ASSOCIATED NEURODEGENERATION 
Chia-Yu Chung 
Nancy M. Bonini 
 
TDP-43 aggregation is the pathological hallmark of amyotrophic lateral sclerosis (ALS) 
and frontotemporal lobar degeneration with ubiquitinated inclusions (FTLD-TDP). To 
define pathways important in TDP-43 proteinopathy, a genetic screen for modifiers of 
TDP-43-mediated eye degeneration was conducted in the fruit fly (Drosophila 
melanogaster). This approach and the following studies in the fly identified 
transcriptional elongation factor Ell as a potent dose-dependent modifier. Ell is a shared 
component of little elongation complex (LEC) and super elongation complex (SEC). Our 
studies show that downregulation of additional components in LEC or SEC partially but 
consistently ameliorates TDP-43-associated eye degeneration, implicating both Ell-
associated complexes in TDP-43 toxicity. LEC regulates transcription of RNA 
Polymerase II (Pol II)-transcribed small nuclear RNAs (snRNAs), while SEC mainly 
regulates transcription of select inducible genes harboring paused Pol II including stress-
induced loci. We hypothesized that, in the disease state, TDP-43 increases the activity 
of LEC and SEC, leading to enhanced expression of select target genes that contribute 
to neurodegeneration. Our results support this hypothesis by showing that select targets 
of LEC and SEC become upregulated in fly heads expressing TDP-43 compared to 
controls. Among upregulated targets, U12 snRNA and a stress-induced long non-coding 
RNA (lncRNA) Hsrw were shown to functionally contribute to TDP-43-induced 
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degeneration in Drosophila. The increase in U12 snRNA leads to elevated activity of the 
U12-dependent spliceosome, assessed by examining U12-dependent splicing events. 
Among the known U12 targets, the splicing of genes CG15735, CG16941 and CG11839 
were shown to be upregulated selectively by TDP-43. In addition, the novel target of 
TDP-43 Hsrw was identified by polytene chromosome association of TDP-43 and SEC 
components Lilli and Ell in the fly. We extended the findings of Hsrw to show that the 
human orthologue Satellite III repeat (Sat III) is elevated in both a human cellular 
disease model of TDP-43 toxicity, and FTLD-TDP patient tissue. Furthermore, TDP-43 
was shown to interact with human ELL2 by co-immunoprecipitation from human HEK293 
cells. These findings support a model whereby TDP-43 promotes the LEC and SEC 
activities through an interaction with ELL2, leading to abnormal activation of LEC and 
SEC target genes that contribute to degeneration. These studies reveal the critical roles 
of Ell and Ell-associated complexes in TDP-43 toxicity, identify important downstream 
targets, and provide potential therapeutic strategies to combat TDP-43-associated 
neurodegeneration. 
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CHAPTER 1 : INTRODUCTION 
THE ROLES OF ELL-CONTAINING TRANSCRIPTIONAL ELONGATION COMPLEXES 
IN TDP-43-ASSOCIATED NEURODEGENERATION 
 
 
2 
	ALS/FTD and TDP-43	
Amyotrophic lateral sclerosis (ALS; OMIM no. 105400) and frontotemporal dementia 
(FTD; OMIM no. 600274) are two neurological disorders with distinct clinical features yet 
share common pathogenic mechanisms 1-4. ALS is the most common motor neuron 
disease, resulting from loss of upper and lower motor neurons in the motor cortex, the 
brainstem and spinal cord, which leads to fatal paralysis.  FTD is the second most 
common cause of early onset dementia, caused by progressive neuron death in the 
frontal and temporal lobes. This results in changes in behavior, personality and/or 
language. Increasingly, evidence indicates that ALS and FTD may be within the same 
disease spectrum. First, about 15% of ALS patients develop the symptoms of FTD and 
vice versa 5-7. Second, genetic mutations in shared genes link these two diseases 1,2,8. 
Among the genes bearing causal mutations for both diseases, TAR DNA-binding protein 
43 (TDP-43) further connects these two diseases. In 97% of ALS and 45% of FTD 
(FTLD-TDP/FTLD-U) patients, TDP-43 was identified to be the major component of 
aggregates in the central nervous system 9,10. In the neurons and glia containing TDP-43 
inclusions, physiological diffused nuclear TDP-43 is cleared and cytoplasmic aggregates 
of full length and truncated TDP-43 are observed with abnormal hyperphosphorylation 
and ubiquitination 9,10.  
 
TDP-43 is a DNA and RNA binding protein with the molecular weight of 43 kDa, which 
was discovered and named for its ability to bind transactive response (TAR) element of 
human immunodeficiency virus type 1 (HIV-1) 11. The total length of TDP-43 is 414 
amino acids. It contains a N-terminal domain (NTD) including a nuclear localization 
signal, two RNA recognition motifs (RRMs) with a nuclear export signal within the 
second RRM domain and a C-terminal domain (CTD). The CTD containing QN-rich 
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residues is implicated in the aggregation propensity of TDP-43 and is where most of 
ALS/FTD-associated mutations are located 12-14. TDP-43 is involved in various cellular 
processes, including splicing regulation, microRNA processing, RNA stability, gene 
expression, RNA translocation between nucleus and cytoplasm, stress granule 
regulation, cell proliferation and apoptosis 13,15. Research in different disease models 
shows that both upregulation and depletion of TDP-43 leads to neuron loss, indicating 
that a balanced level of TDP-43 is critical in the nervous system 13,16,17.   
 
Drosophila as a powerful genetic model system 
To understand the mechanisms of TDP-43 protein pathology, animal models have been 
established. Each disease model has its strength, revealing disease mechanisms from 
different angles. Drosophila melanogaster has a short lifespan, conserved genes and 
pathways with humans as well as powerful genetics, providing an extraordinary system 
for unbiased genetic screens to identify novel pathways. The life cycle of each 
generation of the fruit fly is about 10 days; therefore, large numbers of progeny for 
research can be obtained in a short period of time. Moreover, although the genome size 
of Drosophila (1.2 x 108 base pairs) is much smaller than the human genome size (3.3 x 
109 base pairs), around 70% of known human disease genes have fly orthologs in the fly 
based on sequence analysis 18,19. This homology provides an opportunity for elucidation 
of mechanisms that may be involved in human disease. In fact, the smaller genome size 
of the fly reduces the complexity of gene redundancy of mammalian systems, and allows 
quicker and easier interpretation for loss of function studies.  
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The advantages of using Drosophila as a model organism also include a comprehensive 
and versatile toolbox for genetic manipulation. The fruit fly has been used as a model 
organism for more than 100 years, and tools have been developed to manipulate the 
expression of fly genes 20,21. For example, the GAL4-UAS bipartite system is widely used 
for gene manipulation, allowing spatial and temporal expression of exogenous genetic 
constructs 22,23. The system is composed of two parts. In one construct, a tissue specific 
promoter drives the expression of the yeast transcription factor GAL4; in the second 
construct, a desired transgene is combined with an upstream activation sequence 
(UAS), which can be activated by the GAL4. Therefore, the transgene will be selectively 
expressed in the tissue of interest. Additional regulation and modification of GAL4 can 
be used to control the temporal expression. For instance, Gal80ts, a temperature 
sensitive inhibitor of the GAL4 protein, is used to turn on the expression system at higher 
temperature (>30°C), at which the inhibition by Gal80ts is repressed 24. Another method 
is by using a ligand-inducible GAL4 chimera, GAL4-progesterone receptor fusion 
(GeneSwitch), which is activated in the presence of the drug mifepristone (RU486) 25. 
 
Over time, the fly community has generated comprehensive collections of mutants and 
transgenic fly lines. The Bloomington Drosophila Stock center at Indiana University 
(BDSC) held 67,634 stocks at the end of 2017, including a genome-wide RNAi 
collection. There are also other Drosophila stock centers, such as the Vienna Drosophila 
Research Center (VDRC), Kyoto Stock Center (DGRC), Fly Stocks of National Institute 
of Genetics (NIG-FLY) and Zurich ORFome Project (FlyORF). Together, these stock 
centers provide an accessible resource allowing manipulation of almost every gene. The 
extensive resources and toolbox make Drosophila an excellent model organism for 
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genetic screen. Such screens have highlighted various factors in fly disease models of 
neurodegenerative disorders 26,27.  
 
Fly models for TDP-43 toxicity  
The TDP-43 pathologies, which includes nuclear clearance and cytoplasmic 
accumulation of TDP-43, suggests the possibility that degeneration may be caused by 
loss-of-function in the nucleus and/or gain-of-function in the cytoplasm 9,10. Different fly 
diseases models have been used to elucidate mechanisms in TDP-43-associated 
neurodegeneration, including depletion and overexpression of Drosophila TDP-43 
(TBPH) 28-31, and expression of different forms of human TDP-43 32-38. Downregulation of 
TBPH in the fly leads to neuronal defect and shortened lifespan 28-31, indicating that 
normal function of TBPH is important for neuronal function and supporting the loss-of-
function model. Fly TBPH and human TDP-43 share conserved domains, and sequence 
analysis shows 59% amino acid identity between them 39. Both proteins bind to UG 
repeat sequences 39. Furthermore, the phenotype caused by TBPH depletion can be 
rescued by human TDP-43 28, indicating functional conservation between fly and human 
TDP-43. Ectopic expression of TBPH or human TDP-43 also recapitulates features of 
human patients, such as neuron loss, motor disability and decreased lifespan 30-35,37,38. 
Furthermore, at the molecular level, expression of fly and human TDP-43 can lead to 
cytoplasmic TDP-43 aggregation, and ubiquitinated and phosphorylated forms of TDP-
43 aggregates, mimicking human molecular pathologies and potentially modeling the 
gain-of-function toxicity 31,33,36-38. Therefore, dissecting the pathways involved in 
neurodegeneration in these different disease models may reveal mechanistic insights of 
TDP-43 proteinopathy in human disease. 
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In order to elucidate novel and important factors involved in TDP-43-associated 
neurodegeneration, studies in our lab using the Drosophila eye as a platform for genetic 
screening. We identified Drosophila eleven-nineteen lysine-rich leukemia (Ell; also 
known as Su(Tpl)) as a potential modifier of TDP-43-mediated degeneration. The 
Drosophila eye provides a platform for high throughput genetic screening since it is a 
nonessential organ for survival. The fly compound eye is a simple and delicate nervous 
system composed of thousands of neuronal and nonneuronal cells 40. The basic unit is 
ommatidium, which contains 8 photoreceptor neurons and surrounded by 4 lens-
secreting cone cells and 2 primary pigment cells. In between each ommatidium, there 
are 12 accessory cells.  Because the structure of the eye is highly ordered, degeneration 
and cell death can be easily observed as morphological phenotypes, such as rough eye, 
small eye or change of pigmentation. Expression of the human TDP-43 in fly eye leads 
to disruption of eye integrity 37,38, and studies in our lab found that downregulation of Ell 
strongly suppresses the degeneration caused by TDP-43 toxicity. 
 
Transcription elongation factor: Ell 
RNA Polymerase II (Pol II) is a 12-subunit enzyme that synthesizes protein-coding 
mRNAs and non-coding RNAs (ncRNAs). The process is tightly regulated at different 
stages of transcription, including initiation, pausing, elongation and termination. More 
and more attention has been brought toward the understanding of pausing regulation. 
After forming the preinitiation complex, Pol II can pause and accumulate in the proximal 
region (30-60 nucleotides downstream of the transcription start site) 41-43. The release of 
paused Pol II into productive elongation requires the kinase, positive transcription 
elongation factor b (P-TEFb). P-TEFb is composed of the cyclin-dependent kinase 9 
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(CDK9) and cyclin T1 (CYCT1) or CYCT2. It can phosphorylate negative elongation 
factor (NELF), 5, 6-dichloro-1-b-D-ribofuranosylbenzimidazole (DRB) sensitivity-inducing 
factor (DSIF) and Pol II on the carboxy-terminal domain (CTD). NELF and DSIF are 
factors working together to set up paused Pol II at the promoter-proximal region. 
Phosphorylation of these 3 factors leads to dissociation of NELF from Pol II and 
productive transcription elongation.  
 
Indicated by large scale genomic studies, the release of paused Pol II into elongation is 
an important rate-limiting step of gene expression, potentially for all active genes 44. 
Depending on the methods and cell type, 40%-70% of active genes show accumulation 
of Pol II at the promoter proximal region. However, studies using drug treatments 
inhibiting P-TEFb and genome-wide sequencing methods show that prevention of Pol II 
from releasing halts almost all transcription. These data suggest that P-TEFb dependent 
pausing regulation may be a highly variable rate-limiting regulatory step for all active 
genes. The importance of pausing regulation has been highlighted by research 
investigating its role on transcription subjected to regulatory control and stimuli, such as 
differentiation signals and heat stress 41-43. Transcriptional pausing regulation allows 
rapid induction of transcription as well as enabling fine-tuning of gene activation. The 
paused Pol II is transcriptionally-engaged and awaiting signaling events, such as 
developmental cues, physiological signals and stress response. Upon stimulation, 
poised Pol II can activate gene expression rapidly and serve as a transcription 
checkpoint for precise and synchronized gene activation upon stimulation. 
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Several factors regulating transcriptional elongation have been identified by in vitro 
biochemical assays; these factors include ELL 45. ELL was isolated from rat liver nuclei 
extract as a factor that promotes the catalytic rate of transcription elongation by 
repressing transient pausing of Pol II 46. Human ELL is a protein containing 621 amino 
acids, which is also capable of simulating transcription elongation like the rat ELL protein 
46. Following the purification and investigation of ELL, two additional ELL-related 
proteins, ELL2 and ELL3, were also characterized in mammalian cells 47,48. Through 
sequence comparison, ELL2 and ELL3 were identified and cloned for in vitro 
characterization. The ELL2 open reading frame (ORF) encodes a 640-amino acid 
protein 48, while ELL3 ORF encodes a protein containing 397-amino acids, which is 
testis specific based on Northern blot analysis in different tissues 47. The alignment of all 
three proteins by CLUSTAL O (1.2.4) multiple sequence comparison is shown in Figure 
1-1. Analysis by Clustal 12.1 shows that ELL and ELL2 share 49.43% identity; ELL and 
ELL3 share 32.9% identity; ELL2 and ELL3 share 31.97% identity (Table 1-1). 
Biochemically, all three ELL family proteins can increase the catalytical rate of Pol II 
transcription elongation 46-48. In vivo studies indicate that the function of ELL3 is distinct 
from the other two. By using mouse embryonic stem cells, ELL3 was shown to occupy 
enhancer regions for priming of gene activation for proper differentiation 49.  
 
 
9 
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Figure 1-1. Alignment of human ELL, ELL2, ELL3 and Drosophila Ell 
Comparison of protein sequences of ELL, ELL2, ELL3 and fly Ell by CLUSTAL O 
(1.2.4) multiple sequence comparison. 
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Table 1-1. Percentage identity matrix created by Clustal 12.1 
 Human ELL Human ELL2 Human ELL3 Fly Ell 
Human ELL 100.00 49.43 32.90 30.38 
Human ELL2 49.43 100.00 31.97 28.73 
Human ELL3 32.90 31.97 100.00 20.73 
Fly Ell 30.38 28.73 20.73 100.00 
 
The ELL family proteins are highly conserved in mammal and nonmammal species 50. In 
Drosophila, Ell is the orthologue with a conserved function in promoting Pol II elongation. 
Ell was cloned and shown to increase catalytic rate of Pol II elongation in vitro 51. 
Although the neighbor-joining phylogenic tree indicates that fly Ell is equally divergent 
from human ELL family proteins (Figure 1-2), according to sequence alignment, fly Ell is 
more similar to human ELL (30.38% identity) and ELL2 (28.73% identity) than ELL3 
(20.73% identity) (Figure 1-1 and Table. 1-1). Ell was also shown to regulate heat shock 
gene induction upon heat stress in vivo. By chromosome 
immunostaining in the fly salivary gland, Ell was found to 
co-localize with active elongating Pol II under heat 
stress treatment at heat shock loci, which have been 
used as an established model for investigating the 
regulation of paused Pol II in Drosophila 51,52.  
 
The heat shock response is highly conserved for the protection of cells from a heat 
stress-induced proteotoxic environment 53,54. Upon heat shock and other stresses, heat 
shock genes are rapidly and strongly induced. Heat shock proteins encoded by these 
genes are molecular chaperones that maintain proteostasis and promote cell survival. 
Research on heat shock genes in Drosophila is one of the early studies that indicates 
the existence of a transcriptional elongation control mechanism. In Drosophila cells, Pol 
Figure 1-2. A phylogenic 
tree for human ELL family 
proteins and fly Ell 
A neighbor-joining phylogenic 
tree shows that human ELL 
and ELL2 are less divergent. 
 
 
12 
II was found to be transcriptionally engaged and form a nascent RNA chain of about 25 
nucleotides at one of the major heat shock genes, HSP70, prior to heat shock treatment 
55. The paused Pol II can be released to synthesize the full-length HSP70 transcription 
unit upon heat stress treatment 56. In the fly, staining of the salivary gland polytene 
chromosomes is often used for study of heat shock response. In the salivary gland of the 
3rd instar larvae, the chromosomes go through multiple rounds of replication without cell 
division, resulting in giant polytene chromosomes. This provides a unique opportunity to 
study the relationship between chromatin structure and transcription. Upon heat shock, 
stress genes are actively expressed and causes heat shock “puffs” on the polytene 
chromosomes, such that the major heat shock loci and encoded genes have been well 
characterized and identified 57-63. Regulations of the transcription elongation of heat 
shock genes is conserved in mammals 64,65. 
 
Ell is involved in SEC and LEC 
Ell has been reported to be part of two elongation complexes: super elongation complex 
(SEC) and little elongation complex (LEC) 66, and these complexes are highly conserved 
from Drosophila to human (Table 1-2 and Figure 1-2). ELL was first identified and 
named as a gene that fuses to mixed-lineage leukemia (MLL) in acute myeloid leukemia 
50. MLL is located at chromosome 11 band q23, where aberrant translocation occurs 
frequently in hematologic malignancies. In these cases, the abnormal chromosome 
translocation leads to an in-frame fusion of the N terminus of MLL to the C-terminal part 
of various proteins with very little sequence similarity. Frequent fusion partners of MLL 
include ELL, AFF1, AF9, ENL and AF10 50,67. To better understand the relationship 
among these factors, the Shilatifard group generated cell lines expressing major MLL-
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chimera complexes and purified them for mass spectrometry analysis. This approach led 
to the isolation of the SEC 68. The composition of SEC was also investigated and 
reported using tagged normal proteins 69. The isolation of SEC was also reported by the 
Zhou and the Kiernan groups through purification of transcription factors associated with 
Tat protein of human immunodeficiency virus type 1 (HIV-1) virus, which hijacks host 
transcription machinery for promoting transcription elongation for viral gene expression 
70,71.  
 
Table 1-2. Conserved genes involved in SEC and LEC from Drosophila to human 
Super Elongation Complex (SEC) 
Drosophila melanogaster Homo sapiens 
Gene   CG# Gene NCBI Gene ID 
Su(Tpl)/Ell CG32217 
ELL/ELL1  8178 
ELL2 22936 
ELL3 80237 
Eaf CG11166 
EAF1 85403 
EAF2 55840 
lilli CG8817 
AFF1 4299 
AFF2 2334 
AFF3 3899 
AFF4 27125 
ear CG4913 
MLLT1/ENL 4298 
MLLT3/AF9 4300 
Cdk9 CG5179 CDK9 1025 
CycT CG6292 CCNT1 904 
Little Elongation Complex (LEC) 
Drosophila melanogaster Homo sapiens 
Gene   CG# Gene NCBI Gene ID 
Su(Tpl)/Ell CG32217 ELL/ELL1 8178 
Eaf CG11166 
EAF1 85403 
EAF2 55840 
Ice1 CG13550 KIAA0947/ICE1 23379 
Ice2 CG10825 NARG2/ICE2 79664 
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The components of SEC include ELL family proteins ELL, ELL2 and ELL3, AF4/FMR2 
family member 1 (AFF1; also known as AF4), AFF4, eleven-nineteen leukemia (ENL) 
and ALL1-fused gene from chromosome 9 (AF9), and P-TEFb 66. AFF4 is the scaffold 
protein that directly interacts with P-TEFb, ENL/AF9 and ELL family proteins and is 
essential for SEC assembly 68. The conservation of SEC in Drosophila was reported by a 
study that used a flag-tagged C terminus of Ell in fly S2 cells. Isolation by flag-affinity 
chromatography and analysis by mass spectrometry identified the fly SEC, which 
contains Ell (human ELL, ELL2 and ELL3-related), Lilli (human AFF1/4-related), Ear 
(human ENL/AF9-related) and P-TEFb 69,72 (Figure 1-3). P-TEFb is the kinase 
responsible for releasing paused Pol II. Containing P-TEFb, SEC has been shown to 
activate transcription through pausing regulation for genes involved in immediate 
responses, including developmental genes and stress-induced genes 68,73 (Figure 1-4). 
 
 
Figure 1-3. Schematics of SEC and LEC in fly and mammals 
SEC and LEC are highly conserved from Drosophila to mammals. 
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Identified targets of SEC include developmental genes. One study that identified the 
SEC complex through MLL-chimera also showed that in leukemia cell lines, SEC 
component AFF4 is responsible for the expression of developmental genes HOXA9 and 
HOXA10; these genes are often upregulated in cells bearing an MLL translocation 68. 
This study suggests that in leukemia, the fusion of MLL and SEC components leads to 
premature release of paused Pol II and increased levels of developmental genes. The 
role of SEC in regulating transcription elongation on developmental genes was also 
demonstrated in mouse embryonic cells in response to retinoic acid (RA) and human 
HCT-116 cells in response to serum 73. These results show that SEC is responsible for 
the rapid induction of a small subset of genes upon exposure to developmental signals. 
These genes have paused Pol II prior to stimulation, except one gene, Cyp26a1, whose 
induction requires SEC in the absence of paused Pol II, indicating there might be other 
mechanisms for rapid induction of transcription that involves SEC. 
 
Another group of identified SEC targets are heat shock genes. Given that heat shock 
gene regulation is a well-established model for pausing regulation and that SEC is 
involved in the regulation of transcriptional pausing, the regulation of heat shock genes 
by SEC was tested. Chromosome immunostaining in Drosophila salivary gland showed 
Figure 1-4. The function of SEC 
SEC activates transcription,  
mostly through pausing regulation,  
for genes involved in immediate 
responses 
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that the major component of SEC, Lilli, colocalizes with Ell and elongating Pol II on the 
chromosomes 68. After heat shock treatment, Lilli co-localizes with Ell on the heat shock 
loci together with elongating Pol II, suggesting that SEC releases paused Pol II on heat 
shock genes 68. Studies using chromatin immunoprecipitation and quantitative PCR 
(ChIP-qPCR) and qPCR confirmed that the scaffold protein of SEC, AFF4, is also bound 
to HSP70 and is required for its induction upon heat stress 68.  
 
In mammals, besides the SEC complex, there are 2 related complexes: SEC-like 2 
(SEC-L2) and SEC-like 3 (SEC-L3) (66,72 and Figure 1-3). In mammals, except AFF1 and 
AFF4 which are involved in SEC, the AFF family also includes AFF2 (also known as 
FMR2) and AFF3 (also known as LAF4). These proteins share conserved N-terminal 
and C-terminal regions. SEC-L2 and SEC-L3, containing AFF2 and AFF3 respectively, 
were biochemically purified from human cells. Similar to SEC, SEC-like complexes also 
contain the kinase P-TEFb and ENL or AF9, but ELL family proteins were not identified 
as components involved. Genome wide studies showed that SEC, SEC-L2 and SEC-L3 
regulate different sets of genes 72. In addition, although all 3 complexes can 
phosphorylate Pol II CTD in vitro, only SEC is responsible for the induction of Hsp70 
under heat shock in vivo 72. These different complexes in mammals are predicted to 
expand the regulatory ability of cells in response to different cellular signals. 
 
Ell is also identified to be involved in LEC (Figure 1-5). In the study identifying 
components that interact with Drosophila Ell, two proteins Ice1 and Ice2 were isolated as 
well as the components of SEC (Ice stands for “interacts with the C terminus of Ell”) 69. 
Ice1 and Ice2 interact with Ell and Eaf, but not other components of SEC. This led to the 
identification of LEC, which is composed of Ell, Eaf, Ice1 and Ice2. Ell is implicated in 
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enhancing transcription elongation of target genes of LEC 74. The major transcriptional 
targets of LEC are Pol II-transcribed small nuclear RNAs (snRNAs) (Figure 1-5). ChIP-
seq studies using Ell and Ice antibodies identified snRNA genes as sites of LEC and Pol 
II enrichment 69. RNA sequencing (RNA-seq) with Ell and Ice1 depletion also show that 
Pol II-transcribed snRNA genes are the most altered class of genes in LEC 
downregulated cells 69.  
 
 
 
snRNAs are short non-coding RNAs that form small nuclear ribonucleoprotein particles 
(snRNPs). snRNPs further assemble with numerous proteins into the spliceosomes, 
functioning in pre-mRNA splicing 75. Splicing is an essential step of gene expression, 
which can also increase the number of unique proteins from a single pre-mRNA species. 
Splicing is catalyzed by the spliceosomes of which there are two types: the U2-
dependent spliceosome (also known as the major spliceosome), which is responsible for 
more than 99% of the splicing events, and the U12-dependent spliceosome (also known 
as the minor spliceosome), which is less abundant. The U2 spliceosome includes 
snRNPs: U1, U2, U4, U5 and U6. The U12 spliceosome is composed of U11, U12, 
U4atac, U5 and U6atac snRNPs 76,77 (Table 1-3). In addition to the snRNAs involved in 
the minor or major spliceosomes, there is another snRNA U7, which is involved in the 
maturation of replication-dependent histone mRNA 78. U1, U2, U4, U4atac, U5, U7, U11 
Figure 1-5. The function of LEC 
LEC is responsible for the 
transcription of snRNAs. 
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and U12 are transcribed by Pol II, whereas U6 and U6atac are generated by RNA 
polymerase I (Pol I). 
 
Table 1-3. Major vs Minor spliceosome snRNAs 
Spliceosome U2-dependent/major U12-dependent/minor 
snRNAs 
U1 U11 
U2 U12 
U5 U5 
U4 U4atac 
U6 U6atac 
 
The composition and function of LEC is highly conserved from Drosophila to mammals. 
The orthologues of Ice1 and Ice2 in human are ICE1 and ICE2, respectively 69. Based 
on biochemical purification, human LEC is composed of ELL family proteins, 
EAF1/EAF2, ICE1 and ICE2 69. In human HCT-116 cells, a protein ZC3H8 was also co-
purified with LEC 74. ICE1 is the scaffold protein which is critical for LEC assembly, 
proper localization of LEC in subnuclear bodies as well as downstream target expression 
74. ChIP-seq using HCT-116 cells shows that LEC subunits occupy Pol II-transcribed 
snRNA genes, and consistently RNA-seq study found that downregulation of ICE1 leads 
to a global reduction of snRNA expression 74. Pol II ChIP-seq analysis, comparing cells 
with ICE1 depletion to control cells, further shows that depletion of ICE1 decreases Pol II 
occupancy on LEC-bound snRNA genes 74.  
 
Implications of the roles of LEC and SEC in diseases	
The disrupted function of SEC has been directly associated with human disorders 
including immunodeficiency, cancer and developmental syndromes 79-82. SEC is also 
critical for HIV-1 replication 70,71. In HIV-1 gene expression, elongation of paused Pol II 
near the transcription start site is a major rate-limiting step. The Tat protein encoded by 
HIV-1 is an RNA binding protein, which binds to Tat response element (TAR). Together, 
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they recruit SEC to the 5’ end of all viral transcripts to produce full length products. 
Another disease associated with disrupted SEC activity is leukemia 68. As discussed 
previously, many components of SEC have been found as translocation partners with 
MLL in disease. In leukemia cells carrying an MLL translocation, depletion of the 
essential component of SEC AFF4 results in loss of HOXA9 expression, which is a key 
target of MLL fusion proteins. The involvement of SEC in MLL fusion proteins suggests 
that the regulation of transcription elongation may be disrupted and contribute to MLL-
rearranged leukemias. Germline gain-of -function mutations in AFF4 were identified to 
be the cause of the developmental disorder CHOPS syndrome 83. The name CHOPS is 
an abbreviation for features of the disease, including cognitive impairment, coarse 
facies, heart defects, obesity, pulmonary involvement, short stature and skeletal 
dysplasia. ChIP-seq analysis suggests that in the disease, transcriptional elongation is 
disturbed by altered binding of AFF4 and cohesin on chromosomes 83. 
 
Although neither LEC or SEC has been implicated in neurodegenerative disorders, 
misregulations of targets of LEC and SEC have been reported in neurodegeneration. As 
introduced and discussed before, the targets of LEC are Pol II-transcribed snRNAs, 
which are involved in splicing. Global splicing alterations have been observed by 
genome-wide analysis in both FTD and ALS patients 84,85. Furthermore, in ALS patient 
brain tissue and human cell disease models, the levels of several snRNAs are reported 
to be altered, with both higher and lower levels 86,87. Onodera’s group showed that the 
levels of U1, U2, U4atac and U6atac were significantly decreased in SH-SY5Y 
neuroblastoma cells treated with TDP-43 siRNA compared to control cells 86. They also 
showed that U12 levels are decreased in ALS affected tissues, including spinal cord, 
motor cortex and thalamus, but not in unaffected tissues, including cerebellum, kidney 
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and muscle. However, Yamanaka’s group reported that U4, U5 and U6 are upregulated 
in SH-SY5Y cells with TDP-43 downregulation compared to control cells, and that 
several snRNAs including U1, U2, U4, U5 U11 and U12 are upregulated in spinal cord 
tissue of ALS patients 87. These studies indicate that in TDP-43-associated diseases 
snRNA levels and the spliceosome functions are disrupted, although there are 
discrepancies on the changes observed. 
 
The minor spliceosome was discovered about a decade later than the discovery of the 
major spliceosome and has been studied less; however, more attention has been 
brought to it because of its involvement in diseases including neurodevelopmental and 
neurodegeneration disorders 88,89. A point mutation in RNU12 encoding the U12 snRNA 
has recently been reported to be associated with early onset cerebellar ataxia (EOCA). 
EOCA is characterized by progressive cerebellar ataxia, brisk tendon reflexes and 
sensory loss. The mutation (84C>T) is located on one of the stem loop structures and is 
predicted to weaken the stem-closing base pairing and potentially affect protein 
interactions and spliceosome assembly 90. Other known diseases associated with 
defects in minor spliceosome components include Microcephalic Osteodysplastic 
Primordial Dwarfism type I/Taybi-Linder Syndrome (MOPD1/TALS), Myelodysplastic 
Syndrome (MDS), Roifman syndrome (RFMN), Lowry Wood Syndrome (LWS) and 
Isolated Growth Hormone Deficiency (IGHD) 89,91-95. Three of these diseases 
(MOPD1/TALS, RFMN and LWS), share clinical features of abnormal brain development 
related to cephalon-skeletal dysplasia, intrauterine and postnatal growth retardation and 
microcephaly.  
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The minor spliceosome is also associated with neurodegeneration. In addition to ALS, 
another neurodegenerative disease caused by death of motor neurons spinal muscular 
atrophy (SMA), has also been linked to dysfunction of the minor spliceosome. SMA 
results from mutations in the SMN gene, which leads to decreased levels of the SMN 
protein. SMN is essential for assembly of Sm-class snRNPs, including U1, U2, U4, 
U4atac, U5, U7, U11 and U12 snRNPs 96. Studies using different SMA models have 
shown preferential decrease of minor snRNP levels 97-100, implying that the alteration of 
splicing regulated by the minor spliceosome may contribute to the SMA phenotype.  
 
Heat shock genes are one group of identified and characterized targets of SEC. As 
neurodegenerative diseases are associated with the accumulation of misfolded proteins, 
the important role of protein folding machinery maintaining proteostasis has been 
indicated in neurodegeneration through different studies 101,102. Among these, 
misregulation of the heat shock response has been reported to be associated with TDP-
43 proteinopathy 103-105. By using a human cell disease model of TDP-43 toxicity, 
Hsiang-Yu el al. show that Hsp90 inhibitor 17-AAG, which inhibits Hsp90 activity but 
activates HSF-1, Hsp27 and Hsp70, prevent TDP-43 aggregation caused by reactive 
oxygen species (ROS) 104. In another study, Han-Jou el al. demonstrated in a TDP-43 
cellular model that promoting the heat shock response by expression of the master 
regulator HSF1 leads to a decrease of insoluble TDP-43 aggregates and improves cell 
survival 105. In recent work by Berson et al. using fruit fly and human cell models, the 
induction of several heat shock genes was found to be reduced in these disease models, 
and upregulation of Hsc4 and Hsp68 suppressed eye degeneration caused by TDP-43 
toxicity 103. These studies implicate a potential therapeutic role of the heat shock 
response in TDP-43-mediated neurodegeneration. 
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In Drosophila, among the heat shock genes, which typically encode proteins, one gene 
encodes a long non-coding RNA (lncRNA): heat shock response RNA omega (Hsrw) 106. 
The Hsrw locus is composed of 2 exons, which are separated by an intron and followed 
by tandem repeats of 280 bp units. Nuclear and cytoplasmic lncRNAs named Hsrw-n 
and Hsrw-c are produced from this locus. Hsrw is induced dramatically by heat shock 
and is required for normal development and for survival after heat stress 106,107. Hsrw-n 
together with various proteins forms specific nuclear structures named omega speckles 
106, which are thought to serve as dynamic storage sites for RNA-processing and 
associated proteins. Hsrw is also involved in other pathways potentially functioning in 
maintenance of cellular homeostasis 106. In human cells, the functional orthologue of 
Hsrw is the Satellite III repeat RNA (Sat III) 108. Sat III is encoded by the Sat III repeat 
sequences mainly located in the pericentrimeric region of human Chromosome 9 109. 
The size of Sat III repeat RNA has been reported to be 2-5 kb, with the basic repeat unit 
of Sat III being a pentamer sequence GGAAT, which can be interrupted by the 
terminator sequence CAAC(C/A)CGAGT 110. Like Hsrw, Sat III is induced by heat stress 
and forms a comparable nuclear structure called the nuclear stress body (nSB) at the 
site of synthesis 109. The roles of these heat stress-induced non-coding RNAs in 
neurodegenerative diseases remain to be explored. 
 
The new findings of the thesis adding to the field 
The main findings of my thesis work include: 1) the identification of Ell and Ell-containing 
transcription elongation complexes LEC and SEC as modifiers of TDP-43 toxicity in the 
fly. 2) demonstration that the levels of several LEC target snRNAs are upregulated upon 
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TDP-43 expression including U12, which is functionally involved in TDP-43 toxicity. 3) 
that splicing of select U12-dependent spliceosome targets are elevated in TDP-43 fly 
disease model. 4) that TDP-43 co-localizes with SEC specific component Lilli on a 
chromosome locus encoding a stress-induced lncRNA Hsrw. 5) that Hsrw is identified as 
abnormally elevated and functionally important to TDP-43-mediated degeneration. 6) 
that the human orthologue of Hsrw ,Sat III, is increased in human cells with TDP-43 
expression and in FTLD-TDP-43 patient tissue. 7)  that TDP-43 physically interacts with 
one of the human orthologues of Ell, ELL2.  
 
These findings suggest a model in which TDP-43 promotes the activities of LEC and 
SEC through interaction with ELL2, leading to the upregulation of specific targets of LEC 
and SEC. This upregulation results in misregulation of splicing and cell homeostasis and 
contributes to TDP-43-associated neurodegeneration (Figure 1-6). These findings reveal 
important roles of LEC and SEC in TDP-43 toxicity and link transcription elongation 
complexes to neurodegeneration for the first time, identify important downstream targets 
and provide potential therapeutic insights for TDP-43-mediated neurodegenerative 
diseases. 
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Figure 1-6. The model for the roles of LEC and SEC in TDP-43-mediated 
neurodegeneration 
25 
 
CHAPTER 2: MANUSCRIPT 
ABERRANT ACTIVATION OF NON-CODING RNA TARGETS OF TRANSCRIPTIONAL 
ELONGATION COMPLEXES CONTRIBUTES TO TDP-43 TOXICITY 
Chia-Yu Chung, Amit Berson, Jason R. Kennerdell, Ashley Sartoris, Travis Unger, Sílvia 
Porta, Hyung-Jun Kim, Edwin R. Smith, Ali Shilatifard, Vivianna Van Deerlin, Virginia M-
Y Lee, Alice Chen-Plotkin, and Nancy M. Bonini 
 
 
This chapter is a manuscript in press at Nature Communications. 
The contributions of CYC are: 1) verification of the suppression effects of SEC components by 
detailed characterizations of the suppression effect and by various control experiments in the fly. 
2) raising and testing the hypothesis that both SEC and LEC are involved in TDP-43 toxicity. 3) 
demonstration of the involvement of LEC in TDP-43-mediated eye degeneration 4) demonstration 
of Ell as a dose-dependent modifier by showing that upregulation of Ell enhances TDP-43-caused 
eye degeneration. 5) characterization of Ell as a modifier in the fly nervous system. 6) 
identification of important downstream targets of LEC and SEC, and demonstration of the 
functional involvement of these targets in fly disease models. 6) extension of the findings from fly 
disease models to a human cell disease model and FTLD-TDP patient tissues by developing 
qPCR primers and assessing the human repetitive RNA Sat III in RNA samples collected by 
collaborators. 7) determination of the RNA and protein levels of human ELL and ELL2 using 
samples from a human cell disease model and/or human patient tissues (RNA samples were 
collected by collaborators) 8) demonstration of the interaction of TDP-43 and human ELL2 using 
human HEK293 cells. 9) all figure panels except Fig 3c,d and Supplementary Data 1. 10) 
preparation of the manuscript under the supervision of Dr. Bonini. 
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Abstract 
TDP-43 is the major disease protein associated with amyotrophic lateral sclerosis (ALS) 
and frontotemporal lobar degeneration with ubiquitinated inclusions (FTLD-TDP). Here 
we identify the transcriptional elongation factor Ell—a shared component of little 
elongation complex (LEC) and super elongation complex (SEC)—as a strong modifier of 
TDP-43-mediated neurodegeneration. Our data indicate select targets of LEC and SEC 
become up-regulated in the fly ALS/FTLD-TDP model. Among them, U12 snRNA and a 
stress-induced long non-coding RNA Hsrω, functionally contribute to TDP-43-mediated 
degeneration. We extend the findings of Hsrω, which we identify as a chromosomal 
target of TDP-43, to show that the human orthologue Sat III is elevated in a human 
cellular disease model and FTLD-TDP patient tissue. We further demonstrate an 
interaction between TDP-43 and human ELL2 by co-immunoprecipitation from human 
cells. These findings reveal important roles of Ell-complexes LEC and SEC in TDP-43-
associated toxicity, providing potential therapeutic insight for TDP-43-associated 
neurodegeneration.  
 
 
27 
Introduction 
Amyotrophic lateral sclerosis (ALS; OMIM no. 105400) is the most common motor 
neuron disease, resulting from loss of motor neurons in the motor cortex, brainstem and 
spinal cord, whereas frontotemporal dementia (FTD; OMIM no. 600274) is characterized 
by progressive changes in behavior, personality, and/or language due to gradual 
deterioration of the frontal and temporal lobes. Despite differences in primary sites of 
neurodegeneration, these two diseases share neuropathological and genetic 
commonalities as well as clinical overlap 5,6. TAR DNA binding protein 43 (TDP-43) is 
the major component of inclusion bodies in most ALS and in half of FTD known as 
FTLD-TDP 9,10. Both depletion and upregulation of TDP-43 cause neuronal loss, 
indicating that TDP-43 levels are critical in the brain 13,16. TDP-43 is an RNA-binding 
protein with many functions in RNA regulation and metabolism and is one of a number of 
RNA binding proteins associated with ALS and FTD 13,111,112. This leads to an RNA 
dysregulation-centered view of TDP-43 disease mechanisms. TDP-43 however also 
binds DNA and has been shown to regulate transcription11,113,114. The role of 
transcriptional dysfunction in TDP-43 proteinopathies remains largely unexplored. 
 
Drosophila melanogaster has played an important role in elucidating roles of many 
genes in human neurological disease 27,115,116. In Drosophila, expression of human TDP-
43 leads to neuronal degeneration, shorten lifespan and climbing defects, recapitulating 
fundamental disease features and serving as a platform to provide insight into underlying 
pathways and therapeutic targets 37,38. To define novel disease mechanisms associated 
with TDP-43, we used Drosophila to screen for modifiers of toxicity. Our unbiased 
genetic screen uncovered the transcription elongation factor Ell (also known as Su(Tpl)) 
as a novel and robust modulator. Ell is present in two complexes: little elongation 
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complex (LEC) and super elongation complex (SEC) 68,69,72. In Drosophila, LEC, 
containing Ell, Eaf, Ice1 and Ice2, regulates the initiation and elongation of Pol II-
transcribed small nuclear RNA (snRNA) genes 69,74. SEC is composed of Ell, Eaf, Ear, 
Lilli and P-TEFb 66,69. The kinase P-TEFb phosphorylates Pol II, leading to the release of 
paused Pol II into productive elongation. The composition and functions of both 
complexes are highly conserved in mammals 68,72,74. Neither complex has been 
implicated in neurodegenerative disorders. 
 
snRNAs together with a range of proteins form small nuclear ribonucleoproteins 
(snRNPs), which are essential components of the splicing machinery of the 
spliceosome. In both ALS and FTD patients, splicing changes have been observed by 
transcriptome and microarray analyses, implicating aberrant splicing as an important 
disease mechanism 84,117. In ALS and human cell disease models with TDP-43 
depletion, disruption of several snRNA levels has been reported, both higher 87 and 
lower levels 86, but the detailed mechanism and whether these alterations are 
functionally important in disease is unclear. In normal physiology, SEC activity has been 
shown to be specific to select conditions and genes: developmental genes under 
differentiation signals 73, and heat shock genes upon stress 68,72. The critical role of heat 
shock genes in neurodegenerative diseases has been revealed by studies on molecular 
chaperone and other proteins, which maintain proteostasis 101,102. Among the heat shock 
genes, one distinct from others encodes no protein product but rather a long non-coding 
RNA (lncRNA), named Heat shock RNA omega (Hsrω). Hsrω is functionally required for 
normal development and the heat shock response in Drosophila, and is also involved in 
multiple other pathways potentially contributing to cellular homeostasis 106,107. In humans, 
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Satellite III repeat RNA (Sat III) is the functional orthologue of Hsrω 108 and its role in 
neurodegenerative disease is unknown. 
 
Here, we implicate Ell-associated transcriptional elongation complexes LEC and SEC as 
misregulated upon TDP-43 toxicity. We identify key non-coding RNA targets, U12 and 
Hsrω, as abnormally activated and functionally contributing to TDP-43-induced 
degeneration. Extension of these data to disease tissue and demonstration of the 
interaction between TDP-43 and one of the human orthologue of Ell, ELL2, implicates 
misregulation of human Ell orthologues as a contributor to TDP-43-associated 
pathologies.  
 
Results 
TDP-43 toxicity is mitigated by modulation of Ell  
Flies expressing human TDP-43 in the eye show retinal degeneration 37,38. We employed 
these animals to screen for genes that enhanced or suppressed the degeneration of 
TDP-43. In the screen, 2933 fly lines with different genetic modifications were tested. 
Among them, 12 fly lines enhanced TDP-43 toxicity and 23 fly lines showed 
suppression, indicating a limited number of genes can modify TDP-43 toxicity. From this 
screen, we found that knockdown of the gene Ell strongly mitigated TDP-43-induced 
deterioration of the external eye and internal retina (Fig. 1a, b and Supplementary Fig. 
1a). Furthermore, up-regulation of Ell enhanced TDP-43 toxicity with more severe 
external eye and internal retinal degeneration (Fig. 1a, b and Supplementary Fig. 1a). 
These data indicated that Ell is a potent dose-dependent modifier of TDP-43, with Ell 
knockdown or up-regulation on its own having no effect on eye morphology 
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(Supplementary Fig. 1b). A RNAi control line against Luciferase did not mitigate TDP-43-
mediated eye degeneration (Fig. 1a, b). 
 
Ell protein is a shared component of two transcriptional elongation complexes: LEC and 
SEC (Fig. 1c). In order to investigate whether the suppression due to Ell knockdown was 
through one or the other of these complexes, we downregulated additional components 
of LEC and SEC in the presence of TDP-43. Reduction of SEC components ear and lilli 
partially suppressed the external and internal retinal deterioration conferred by TDP-43, 
as did reduction of LEC component Ice1 (Fig. 1d, e and Supplementary Fig. 1a). The 
rescue effect of any of these components was not as strong upon depletion of the 
shared component Ell, suggesting that both LEC and SEC contribute to TDP-43 toxicity. 
Depletion of any of the components on their own had no effect on eye integrity 
(Supplementary Fig. 1b).  
 
The levels of the TDP-43 protein were assessed by western immunoblot. These data 
indicated that enhancement by Ell up-regulation or suppression by lowered levels of Ell 
or other components of LEC or SEC was not through modulating the levels of TDP-43 
protein (Supplementary Fig. 1c). We further confirmed that the GAL4-UAS expression 
system was not impacted by any of these components by examining the levels of a 
control protein β-galactosidase (β-gal) (Supplementary Fig. 1d). Additional fly lines, 
including a genetic mutation of Ell, and two RNAi lines of Ice1 with proper controls were 
tested and showed consistent suppression effect on TDP-43-caused eye degeneration 
(Supplementary Fig. 1e). 
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To extend these studies to the nervous system generally, we expressed TDP-43 in all 
neurons in the adult animal using a conditional drug-inducible driver line. With 
expression in the adult fly brain induced by RU486, TDP-43 animals consistently show 
an age-associated decline in climbing ability, indicative of neural dysfunction (Fig. 1f, 
Supplementary Fig. 1f and 38). Knockdown of Ell, although showing no effect on its own, 
restored climbing ability to normal without affecting TDP-43 protein levels (Fig. 1f, g and 
Supplementary Fig. 1g). We also assessed the suppression effect of Ell on TDP-43 
toxicity in the nervous system by lifespan assays using the drug-inducible neuronal 
driver. Knockdown of Ell on its own caused mild but statistically significant extension of 
lifespan, and downregulation of Ell caused a mild suppression of TDP-43-shorten 
lifespan and a shift of the early stage of the lifespan curve (Supplementary Fig. 1h). 
Lifespan assays assessing Ell knockdown effect on TDP-43 toxicity were also tested by 
using a ubiquitous drug-inducible driver, showing consistent results that Ell 
downregulation has some effect to mitigate TDP-43 toxicity (Supplementary Fig. 1I). 
These data indicate that increased activity of both Ell-complexes LEC and SEC may 
contribute to TDP-43-mediated degeneration in the nervous system.  
 
LEC snRNA target U12 contributes to TDP-43 toxicity  
To determine whether the activity and function of LEC and SEC are promoted by TDP-
43, we assessed the downstream targets in the fly disease model. Targets of LEC are 
Pol II-transcribed snRNAs 69,74. We therefore used Northern blot analysis to assess the 
levels of snRNAs U1, U2, U4, U4atac, U5, U7, U11 and U12 in fly heads, with or without 
added TDP-43 driven by a ubiquitous drug-inducible driver. TDP-43 expression 
significantly increased levels of U1, U4, U7 and U12 (Fig. 2a and Supplementary Fig. 
2b). Importantly, knockdown of Ell restored the levels of the elevated snRNAs back to 
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normal without affecting TDP-43 expression (Fig. 2a and Supplementary Fig. 2a, b). 
These data suggest that misregulation of snRNA components may be a consequence of 
disrupted Ell function in the animals and contribute to TDP-43 toxicity.  
 
To test the functional role of the snRNAs in TDP-43-induced degeneration, we 
determined whether downregulation of the elevated snRNAs could mitigate toxicity. We 
examined fly lines predicted to downregulate various snRNAs (U1, U4, U7, U12). There 
was little effect of fly lines directed to U1 and U4 (there are multiple copies of these 
snRNAs in the genome making interference challenging), and U7 depletion suppressed 
the external eye but did not suppress the internal deterioration. Although we cannot 
exclude the potential importance of U1, U4 and U7, we focused on U12. U12 knockdown 
partially, but consistently mitigated TDP-43-associated retinal disruption (Fig. 2b, c and 
Supplementary Fig. 2c), indicating that misregulation of U12 levels is functionally 
important to TDP-43 toxicity. We confirmed that U12 downregulation had no effect on 
TDP-43 protein, and that reduction of U12 on its own did not affect the eye 
(Supplementary Fig. 2d, e). U12 is a component of the minor spliceosome (U12-type 
spliceosome), indicating that targets of the minor spliceosome may be misregulated by 
TDP-43.  
 
There are 18 genes containing a U12-type intron in Drosophila 100. Total RNA from fly 
heads was prepared for reverse transcription quantitative PCR (RT-qPCR) with qPCR 
primer sets spanning the U12-regulated introns to assess the levels of spliced gene 
products (Fig. 2d). Among the 18 genes, six (CG16941, CG11839, CG33108, CG11328, 
CG15735 and CG3294) were up-regulated with expression of TDP-43, with the other 12 
genes not affected (Fig. 2e; Supplementary Fig. 2f, g), indicating increased U12 levels 
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leads to elevation of specific minor spliceosome targets. Knockdown of Ell corrected the 
levels back to normal (Fig. 2e; Supplementary Fig. 2g), consistent with the ability of Ell 
downregulation to normalize the levels of U12 and protect from TDP-43 toxicity. To 
further determine whether the elevation resulted from transcription or splicing, we 
assessed the levels of the unspliced transcripts. The unspliced products of 3 genes, 
CG33108, CG11328 and CG3294 were also increased upon TDP-43 expression, 
indicating a change in total transcript levels (Supplementary Fig. 2g). The unspliced RNA 
levels of the 3 genes CG15735, CG16941 and CG11839 were not altered significantly 
by the presence of TDP-43, indicating that the splicing of these U12-regulated introns 
was increased (Fig. 2e). These data indicate that the U12-type spliceosome is 
abnormally activated in the fly disease model to cause disrupted regulation of selected 
downstream targets. 
 
TDP-43 and Lilli co-localize at the Hsrω lncRNA locus 
Ell is also a component of SEC and SEC activates transcriptional elongation, which is 
critical for genes involved in developmental signaling pathways and the stress response 
68,72,73. The SEC scaffold protein Lilli binds to and regulates specific targets on the 
chromosomes in Drosophila and human cells 68,72,73. Recently, genome-wide chromatin 
immunoprecipitation (ChIP-seq) shows that Drosophila TDP-43, TBPH, associates with 
chromatin 114. We therefore considered that TDP-43 may co-localize to the same genes 
as Lilli. To explore this, we expressed TDP-43 tagged with YFP in Drosophila salivary 
gland and assessed Lilli and TDP-43 localization on the polytene chromosomes by 
immunostaining. Under ambient temperature, we observed that TDP-43 binds to 
polytene chromosomes with specificity (Fig. 3a). TDP-43 and Lilli each localized to ~115 
sites (Fig. 3a). Most of these were euchromatin regions where active transcription 
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usually occurs. Detailed analysis of the co-localization pattern indicated that TDP-43 and 
Lilli consistently overlapped at 16 sites across chromosomes X, 2R, 3R and 3L (Fig. 3a 
and Supplementary Table 1). Although it is difficult to precisely identify the genes with 
co-localization of TDP-43 and Lilli due to the resolution of polytene bands, these data 
indicate partial overlap of TDP-43 and SEC targets in normal conditions; these genes 
may be important in toxicity. 
 
Upon heat stress, SEC is recruited to major heat shock loci on the polytene 
chromosomes and, further, has been shown to regulate the expression of a major heat 
shock protein Hsp70 68. Dysfunction of the heat shock response, which functions to 
maintain proteostasis, is associated with TDP-43 toxicity 103-105. We therefore probed 
whether TDP-43 co-localized to these targets of SEC. As noted 68, with heat shock Lilli 
localizes to the major molecular chaperones at polytene chromosome sites 63B, 67B, 
95D, 87A and 87C and a unique heat shock locus, 93D that encodes the lncRNA Hsrω 
(Fig. 3b). When we examined co-localization with TDP-43, we noted some co-
localization at 63B (encoding Hsp83) and 67B (encoding small heat shock genes) 
(Supplementary Table 2). Moreover, we observed robust and consistent co-localization 
at 93D in all polytene chromosome spreads examined (Fig. 3b and Supplementary Table 
2); this was a site at which TDP-43 and Lilli also co-localized without added stress 
(Supplementary Table 1), suggesting that this stress-induced lncRNA may be a common 
target of TDP-43 and Lilli. We also assessed the co-localization of TDP-43 and Ell. 
Consistent with the results of immunostaining with Lilli, Ell also co-localized with TDP-43 
at the 93D locus encoding Hsrω (Supplementary Fig. 3a). Precision nuclear run-on 
sequencing (PRO-seq) has shown that pol II is paused on Hsrω 118, and chromatin 
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staining shows that SEC components, Ell and Lilli, co-localize with elongating Pol II at 
the 93D locus after heat stress 68, both indicating that Hsrω is a target of SEC.  
 
Given the limited resolution of polytene chromosome staining, we analyzed the 
published ChIP-seq data for TBPH 114 and Lilli 69 to better define genes  bound by both 
factors. This analysis showed that TBPH binds to 383 genes and Lilli binds to 4162 
genes (Fig. 3c and Supplementary Data 1). Among them, 328 genes were bound by 
both factors, which comprises ~86% of the genes bound by TBPH and ~8% of the genes 
bound by Lilli (Fig. 3c). Consistent with the polytene data, Hsrω is a target of both TBPH 
and Lilli (Fig. 3d). We therefore considered that Hsrω might be a target of SEC that 
becomes misregulated by TDP-43. 
 
Hsrω functionally modulates TDP-43 toxicity  
The 93D locus encodes nuclear and cytoplasmic lncRNAs referred to as Hsrω-n and 
Hsrω-c, respectively, both of which are induced by stress. Upon heat stress, Hsrω-n 
transcripts are up-regulated at the 93D site 106, with a balanced level of Hsrω being 
critical for the survival and recovery of flies following heat stress 107. Given the striking 
co-localization of TDP-43 and Lilli at the Hsrω locus, we considered that dysregulation of 
Hsrω may occur with TDP-43. RNA from fly heads in the presence or absence of added 
TDP-43 expression was extracted for RT-qPCR and the levels of total Hsrω (Hsrω-c and 
Hsrω-n), and Hsrω-n were determined. Total Hsrω and Hsrω-n were increased ~2-fold 
upon TDP-43 expression (Fig. 4a). Importantly, this misregulation was reduced toward 
normal levels by Ell knockdown (Fig. 4a). These data indicate that Hsrω may be a 
functional target of SEC activity that contributes to TDP-43-associated degeneration. 
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To assess whether misregulation of Hsrω is functionally important to TDP-43 toxicity, we 
reduced the levels of Hsrω in animals expressing TDP-43. Reduction of Hsrω by placing 
animals expressing TDP-43 in trans to an Hsrω null mutation partially mitigated TDP-43-
associated external and internal retinal deterioration (Fig. 4b, c). This was not associated 
with changed levels of TDP-43 protein, and loss of one copy of Hsrω on its own had no 
effect (Supplementary Fig. 4a, b). We also confirm the suppression effect of Hsrω 
downregulation on TDP-43-mediated eye degeneration by a RNAi line with proper 
controls (Supplementary Fig. 4c). The effect of lacking one copy of Hsr⍵ on climbing 
defect caused by TDP-43 was unable to be determined because reduction of Hsr⍵ on its 
own caused a decrease in climbing ability (data not shown). Taken together, these 
findings on the co-localization of TDP-43 and Lilli at the Hsrω gene locus, on elevated 
levels of Hsrω RNAs in TDP-43-expressing animals, and on functional mitigation of 
TDP-43-induced degeneration by modulation of Hsrω levels suggest that the stress-
induced lncRNA Hsrω is a functional target of TDP-43 that contributes to TDP-43-
mediated degeneration. 
 
Sat III is upregulated in a cellular model and in patient tissue 
These data on Hsrω raised the possibility that the functional orthologue of Hsrω in 
humans, the stress-induced Satellite III repeat RNA (Sat III) 108, may become 
misregulated in disease and contribute to toxicity. Although not sharing precise 
sequence similarity, Hsrω and Sat III transcripts share functional features and regulatory 
mechanisms: they are repeats and non-coding in nature; they are induced and 
accumulate at the site of synthesis upon stress, and associate with heterogeneous 
nuclear ribonucleoproteins (hnRNPs) and other RNA-processing factors; they are both 
Pol II-dependent transcripts 106,108,109. Moreover, although Sat III is essential for cell 
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survival after heat shock, upregulation of Sat III promotes cell death and acute 
senescence in various cell models 119,120. We therefore investigated whether Sat III 
transcripts became misregulated by TDP-43.  
 
To assess Sat III levels in mammalian cells, we used human embryonic kidney 293 
(HEK293) cells expressing doxycycline-induced GFP-tagged TDP-43 (GFP-TDP-43) or 
GFP alone. RNA was prepared following 6d of induction, and the levels of Sat III 
transcripts were examined by RT-qPCR. We compared Sat III levels in cells expressing 
GFP-TDP-43 to control cells expressing GFP. TDP-43 expression led to a ~4-fold 
increase in the steady state level of Sat III (Fig. 5a). The Sat III primers were validated 
by heat shock induction of Sat III followed by RT-qPCR analysis (Supplementary Fig. 
5a). Thus, the human counterpart of Hsrω became misregulated upon aberrant TDP-43 
expression in cells.  
 
These findings raised the possibility that Sat III may become dysregulated in human 
disease. To address this, we used RNA prepared from frontal cortex of 13 FTD patients 
(six sporadic or with unknown family history and seven patients with a family history of 
FTD and/or a disease-associated mutation) and six clinically normal controls (Fig. 5b). 
All of the FTD patients had TDP-43 pathology (FTLD-TDP) 121,122. In accordance with our 
studies in the fly and human cells, the results showed that the levels of Sat III transcripts 
were significantly higher in the frontal cortex of FTD patients compared to controls (Fig. 
5b). Case numbers and details are indicated in Table 1. Taken together with the 
functional data from the fly, misregulation of the stress-induced lncRNA Sat III may be a 
contributor to TDP-43-associated disease.   
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TDP-43 and ELL2 proteins interact 
To further dissect the relationship between Ell and TDP-43 and define additional 
mechanisms by which Ell may contribute to TDP-43-mediated neurodegeneration, we 
assessed whether Ell levels were upregulated in disease models; upregulation of Ell 
could lead to increase levels of downstream targets and in this manner contribute to 
TDP-43-mediated neurodegeneration. RNA levels of fly Ell were examined by RT-qPCR 
using RNA extracted from fly heads in the presence or absence of added TDP-43. 
These data showed that Ell is elevated ~50% upon TDP-43 expression (Fig. 6a). We 
next examined human ELL proteins in the HEK293 cell model. In mammals, there are 
three proteins in the ELL family: ELL, ELL2 and ELL3 66, with ELL3 being the most 
distinct based on sequence (~50% identity) and enriched in testis 47. All three ELL 
proteins can be pulled down with factors in LEC and SEC 68,69. We examined the RNA 
levels of ELL and ELL2 in cells expressing GFP-TDP-43 or GFP control by RT-qPCR. 
The results are consistent with the fly data, showing that TDP-43 expression led to a 
50% increase of ELL and ELL2 levels (Fig. 6b). However, when we assessed protein 
levels by western immunoblot, the results indicate that the levels of ELL and ELL2 were 
not changed (Supplementary Fig. 6a). We also examined ELL and ELL2 by RT-qPCR 
using RNA prepared from frontal cortex of the 13 FTD patients with TDP-43 pathology; 
expression levels of ELL and ELL2 were not changed significantly compared to controls 
(Supplementary Fig. 6a). These results, together with the data showing that upregulation 
of Ell on its own does not cause eye degeneration (Fig. 1a and Supplementary Fig. 1b), 
indicate that mechanisms beyond simply a global increase in levels of Ell may be 
involved in TDP-43-associated toxicity.   
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The polytene chromosome immunostaining showed that TDP-43 co-localized with Ell 
and Lilli at the 93D locus (Fig. 3a and Supplementary Fig. 3a), indicating that 
interactions between the proteins might occur. We thus assessed whether endogenous 
TDP-43 interacts with ELL or ELL2 in nuclear extracts of HEK293 cells using co-
immunoprecipitation (co-IP). TDP-43 was immunoprecipitated by an anti-TDP-43 
antibody (Fig. 6c), and western blots then probed for presence of co-
immunoprecipitating ELL or ELL2.  ELL was not detected; however, ELL2 was co-
immunoprecipitated together with TDP-43 (Fig. 6c). This was specific because ELL2 was 
not co-immunoprecipitated with IgG control. These data indicate that TDP-43 interacts 
with ELL2, suggesting that this interaction may contribute to dysfunction of ELL-
associated complexes upon aberrant TDP-43 function.  
 
Discussion 
Misregulation of several transcriptional elongation factors has been reported in diseases, 
including viral pathogenesis and cancer 79,123, yet these factors have not been implicated 
in neurodegenerative disorders. Here we report that Ell and Ell-containing transcriptional 
elongation complexes LEC and SEC are novel modifiers of TDP-43 toxicity. The levels 
of several LEC target snRNAs including U12 are upregulated by TDP-43 proteinopathy. 
Our data suggest that the U12-type spliceosome is abnormally activated and contributes 
to toxicity. Through chromatin immunostaining, we identify a key target of SEC, a stress-
induced lncRNA Hsrω, as aberrantly elevated and functionally important to TDP-43-
mediated degeneration. In addition, we show that the levels of the human orthologue of 
Hsrω, Sat III, is increased in a human cell model and in FTLD-TDP frontal cortex tissue, 
indicating that Sat III dysfunction may contribute to TDP-43-associated disease. Finally, 
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we demonstrate TDP-43 interacts with the one of the human orthologues of Ell, ELL2, 
indicating that the aberrant elevation of LEC and SEC activity in disease may be 
promoted through the interactions between TDP-43 and ELL2 (Fig. 7). These findings 
highlight the critical roles of LEC and SEC in TDP-43-mediated pathologies, and 
highlight that approaches to normalize the activity of human orthologues of the shared 
component Ell may be of therapeutic benefit. 
 
Our data suggest a model whereby SEC and LEC contribute to TDP-43-mediated 
degeneration in parallel (Fig. 7).  We find that that depletion of the shared component Ell 
led to nearly full suppression of TDP-43-mediated eye degeneration, whereas, by 
contrast, downregulation of LEC- and SEC-specific components or downstream targets 
U12 and Hsrω showed only partial suppression, despite the downregulation effect for the 
genes being robust. In our study, we identified important targets that are functionally 
involved in TDP-43-mediated degeneration, but we do not exclude the possibility that 
there may be other targets regulated by LEC and SEC that are important in the disease. 
Furthermore, we show that up-regulation of the shared component Ell enhances TDP-43 
degeneration, and the abnormally elevated levels of LEC and SEC targets caused by 
TDP-43 toxicity can be rescued by Ell depletion. Our study demonstrates that TDP-43-
mediated degeneration can be alleviated by decreasing the activities of LEC and SEC, 
which is predicted to lead to reduction of elongating Pol II on downstream key targets 
and thus lower their levels.  
 
As an RNA binding protein, TDP-43 has been demonstrated to regulate targets through 
direct binding 13,111,124. Our studies propose another layer of regulation: we hypothesize 
that TDP-43 affects transcription through misregulation of LEC and SEC activities, 
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contributing to degeneration. Furthermore, the data showing that TDP-43 interacts with 
ELL2 (Fig. 6c) suggests a mechanism which TDP-43 may promote the activities of LEC 
and SEC at target genes, through interactions of the TDP-43 with ELL2 (Fig. 7).  
 
Our data highlight elements of specificity in TDP-43-associated toxicity. First, we show 
that only selected targets of LEC and SEC are elevated in expression in the fly upon 
TDP-43 expression. The selectivity of targets can be defined by accessory factors 
associated with the LEC and SEC: in human cells, a mediator subunit MED26 has been 
shown to interact through EAF1 and EAF2 and promote the expression of select target 
genes, including a subset of snRNAs and Hsp70 125,126. Other factors like PAF1 and 
integrator, interacting with SEC 127,128, might also contribute to target specificity.  
 
Our data showing that TDP-43 binds to Drosophila polytene chromosomes with 
selectivity (Fig. 3a, b), and that TDP-43 interacts with ELL2 (Fig. 6c), suggest specificity 
could also be defined by TDP-43. In HIV infection and leukemia, the sequence specific 
DNA binding activators, HIV-1 Tat protein and MLL respectively, direct SEC to specific 
target genes for their abnormal expression 68,70,71. Thus, it is possible that TDP-43 serves 
as a sequence specific DNA or RNA binding factor and therefore defines target 
specificity in associated diseases. A second layer of specificity is that, upon increased 
U12 snRNA levels, among 18 target genes with a U12-type intron, only 6 become 
misregulated with TDP-43. The detailed mechanisms by which specificity is established 
is an intriguing question that remains to be addressed.  
 
In models of the motor neuron disease spinal muscular atrophy (SMA), expression levels 
and splicing of several genes containing a U12-type intron are decreased 100. Our data 
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show that the activity of the minor spliceosome is affected in an opposite direction in 
TDP-43 expressing animals, highlighting the importance of a balanced level of the minor 
spliceosome in maintaining normal motor neuron function. Products of 6 minor 
spliceosome-regulated genes were increased with TDP-43, with 3 genes potentially 
regulated through transcription and 3 genes likely through misregulation of splicing (see 
Fig. 2e and Supplementary Fig. 2f, g); among these, expression of 3 genes (CG33108, 
CG16941 and CG11839) are decreased in a fly model of SMA 100. This finding indicates 
misregulation of common target genes in different motor neuron disease models. 
Misregulation of orthologues of some of these genes have been reported in mammalian 
models of ALS and FTD or in human patients: the splicing of a U12-type intron in 
C19orf54, the human orthologue of CG33108, is affected in an ALS transgenic mouse 
model expressing human FUS, which is encoded by a gene that, when mutated, can 
cause ALS and rare cases of FTD 129. Another gene, SF3A1, the human orthologue of 
CG16941, shows altered poly-A usage in ALS patients bearing the C9orf72 GGGGCC 
hexanucleotide repeat expansion 84, the most common known genetic cause of ALS and 
FTD 84,130,131. SF3A1 is also implicated as a novel risk factor in FTD by gene co-
expression network analysis 132. Our findings, together with others, indicate that these 
genes may be critical in TDP-43-associated disorders.  
 
We report that the stress-induced repetitive RNA Sat III is increased in TDP-43-
associated disease, which suggest that the elevation may contribute to neuronal loss 
and degeneration. We used both HEK293 cell disease model and human patient 
samples to verify findings in different systems. Stress genes maintain proteostasis and 
promote cell survival. However, the stress response can be diverse depending on the 
circumstances 133,134. The induction of Sat III by TDP-43 is significant although mild (~4-
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fold; see Fig.5), leading us to consider that expression of TDP-43 may be akin to a 
chronic stress that triggers distinct pathways from those induced by an acute heat shock 
response (whereby Sat III is induced many thousand-fold (see Supplementary Fig. 4)). 
In support of this idea, although Sat III is required for cell survival after heat shock, 
forced expression of Sat III triggers cell death and rapid cellular senescence 119,120. 
Elevated Sat III transcripts have been noted in senescent cells and fibroblasts from 
patients with the premature aging disease Hutchinson-Gilford progeria syndrome 
(HPGS) 135,136. Furthermore, normalization of elevated Sat III largely rescues the mitotic 
dysregulation and senescence phenotype of SIRT6-depleted cells 120, indicating that 
elevated Sat III contributes to age-related cellular abnormalities. These studies support 
our findings and model that elevated Sat III is detrimental and may contribute to TDP-43-
associated neuronal dysfunction. The influence of ELL proteins on the induced Sat III 
levels by TDP-43 is an interesting question that remains to be further investigated. 
 
Given our data in Drosophila, the shared component Ell, whose depletion rescued the 
elevated levels of LEC and SEC targets, may be an effective therapeutic target. 
Importantly, our data also showed that knockdown of Ell on its own did not cause 
deleterious effects like degeneration or compromised mobility, further supporting that Ell 
may be a promising therapeutic candidate (see Supplementary Fig. 1b, f). Domain 
analysis of human orthologues of Ell, ELL and ELL2, identified the N-terminal 150 amino 
acids as critical for elongation function 48,137. Given that the ELL family is also reported to 
display additional activities, such as serving as an E3 ubiquitin ligase for c-Myc 
degradation 138 and inhibiting P53 function 138, a strategy to apply molecules targeting 
domains specific for elongation activity, or even targeting the interaction between ELL 
proteins and the assembly components of LEC and SEC, ICE1 and AFF4 (human 
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orthologue of Lilli), respectively, may be promising. Recent research resolving the 
structure of AFF4 and ELL2 binding interface reveal a cavity that is a potential binding 
site for small molecules to interrupt SEC activity 139. 
 
The therapeutic potential of ELL family proteins may not be limited to TDP-43-associated 
toxicity. Our findings indicate that knockdown of Ell protects against not only TDP-43 but 
also GGGGCC hexanucleotide repeat toxicity (Supplementary Fig. 9), which is also a 
major disease locus for ALS and FTD. These data suggest that shared targets of these 
two toxic insults and of ELL family proteins might be central to degeneration associated 
with these mechanisms.   
 
Methods 
Drosophila melanogaster 
Flies were raised at 25°C. Transgenic flies with TDP-43-YFP and recombinant fly lines 
gmr>TDP-43 and elavGS>TDP-43 are described 37,38. The recombinant fly line 
daGS>TDP-43 was generated with the fly line daughterless-GeneSwitch (dsGS), a 
generous gift from Dr. Veronique Monnier 140. Ice1 RNAi fly line was generated with two 
constructs (SH09112.N and SH09113.N) provided by DRSC/TRiP center. Fly lines used 
are listed in Supplementary Table 3. 
 
Drosophila external eye and internal eye imaging  
Adult female flies (1-2d) were used. For external eyes, flies were anesthetized with ether 
and imaged. For retinal tissue imaging, fly heads were embedded in paraffin blocks and 
sectioned for images of endogenous autofluorescence. Images of retina sections were 
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analyzed by ImageJ to measure the thickness of retina tissue in the middle for 
quantification.   
 
RU486 induction in adult fly 
Adult male flies (0-1d) were collected and aged in vials containing fly media added with 
or without RU486 as indicated (4 mg/ml or 8 mg/ml, 100 μl) to induce gene and RNAi 
expression at 25°C for indicated days. 100% ethanol (EtOH) was used as vehicle. 
 
Adult fly climbing assay  
Adult male flies were collected for RU486 induction. Assays were conducted between 
10-11 am. Plastic vials (height=9.5 cm) were used for the assay. Flies were transferred 
into plastic vials at the density of 25 flies per vial 20 min before the assay. For the assay, 
flies were tapped to the bottom of the vial, and the number of flies climbing above 5.5 cm 
was counted after 15 sec (3 repeats). For each trial, a cohort of 100 flies was assessed 
for each genotype over 21 days.  
 
Fly lifespan assay 
Male flies were collected 0-1 days after eclosion and transferred into vials containing fly 
media with or without RU486 at a density of 20 flies per vial. Flies were transferred to 
fresh media every other day and the numbers of dead flies were scored. For each group, 
200 flies were used in each experiment.  
 
Western blotting 
Adult male fly heads (1-2d unless otherwise noted) were homogenized in Laemmli 
sample buffer (Biorad) with βME, boiled and centrifuged to remove debris. NuPAGE 4-
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12% Bis-Tris gel (Thermo Fisher) was used to run the samples. Proteins were 
transferred to nitrocellulose membrane by the iBlot blotting system (ThermoFisher). For 
human cell samples, cells (~9.6*105) were lysed in RIPA buffer (Cell signaling; #9806) 
supplemented with PMSF and proteinase inhibitor protease inhibitor cocktail (Roche; 
#1183670001). Extracts were sonicated for total 6 min using using QSonica (Newtown, 
CT) water bath sonicator (amplitude = 100, 30 s on, 30 s off). After centrifugation the 
concentrations of the protein samples were measured by Pierce BCA kit (Thermo; 
#23225). Same amount of proteins was prepared for each sample with NuPAGE LDS 
sample buffer (Invitrogen; #NP0007), boiled at 95°C, 5min and run on NuPAGE 4-12% 
Bis-Tris gel (Thermo Fisher). Proteins were transferred to PVDF membrane by the XCell 
SureLock system (Invitrogen). Primary antibodies used were anti-TDP-43 rabbit 
polyclonal antibody (1:5000; Proteintech; #10782-2-AP), anti-β-gal mouse monoclonal 
antibody (1:2000; Promega; #Z378A), anti-α-tubulin rabbit polyclonal antibody 
conjugated with HRP (1:1000; Cell signaling; #9099), anti-ELL rabbit polyclonal antibody 
(1:1000; Proteintech; #51044-1-AP), anti-ELL2 rabbit polyclonal antibody (1:1000; 
Bethyl; #A302-505A), anti-ELL2 mouse monoclonal for co-IP immunoblots (1:1000; 
Santa Cruz; #sc-515276) and anti-GAPDH mouse monoclonal (1: 10,000; AbD Seotec; 
#4699-9555). The secondary antibodies used were goat anti-rabbit IgG-HRP (1:5000; 
Milipore, #AP307P) and goat anti-mouse (1:5000; Jackson ImmunoResearch; #115-035-
146). All blocking and antibody incubations were done in 5% milk in PBS overnight (O/N) 
at 4°C for primary and 1 hr at room temperature (RT) for secondary. Signals were 
developed by ECL plus (ThermoFisher) or ECL prime (GE healthcare) western blotting 
reagents. The images were scanned by Fujifilm LAS-3000 imager (Fujifilm) or 
Amersham Imager 600 (GE healthcare), and quantification was performed using 
ImageJ. The uncropped blots in the main figures are provided in Supplementary Fig. 7. 
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Small RNA Northern blotting   
Total RNAs were extracted from fly heads using Trizol reagent (ThermoFisher; 
#15596026), following the manufacturer’s protocol. RNA quality was checked by gel, and 
0.6-3 μg of total RNA was loaded in 15% TBE-urea gel (ThermoFisher; #EC68852BOX). 
RNAs were then transferred onto nylon membrane (GE HealthCare; #RPN303B) and 
cross-linked by UV. The membrane was then prehybridized by UltraHyb Oligo 
Hybridization Buffer (ThermoFisher; #AM8663) and then hybridized with P32-labeled 
probes overnight at 50°C. To make the probes, DNA oligos were annealed to obtain the 
template for RNA probes, which were synthesized by in vitro transcription using 
MAXIscript T7 kit (ThermoFisher; #AM1312), supplemented with P32-a-UTP. Signals 
were detected by GE Amersham Typhoon 9410 Imager and analyzed by ImageJ for 
quantification. Probes used are listed in Supplementary Table 4. The same blots were 
used to probe 2 different snRNAs: either U1 and U11; U2 and U5; U4 and U7 or U4atac 
and U12. The uncropped scans of the blots are shown in Supplementary Fig. 8. 
 
Drosophila polytene immunohistochemistry 
To obtain larvae in the approximately same developmental stage, fly food was mixed 
with 0.05% bromophenol blue, and light blue wandering larvae were selected for 
experiments. Salivary glands were dissected in PBST (0.05% Tween20) and fixed with 
45% acetic acid and 2% paraformaldehyde for 1 min and transferred into a drop of 45% 
acetic acid on a sigma-coated coverslip. The salivary glands were then squashed onto 
Fisherbrand Superfrost Plus Microscope slides (Fisher Scientific), and liquid nitrogen 
was used to freeze the slides. Slides were blocked at RT for 1 hr, and incubated with 
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anti-GFP mouse monoclonal antibody (1:500; Takara; #632380), anti-Lilli rabbit 
polyclonal antibody (1:500; a generous gift from Dr. Ali Shilatifard) and anti-Ell rabbit 
polyclonal antibody (1:500; a generous gift from Dr. Ali Shilatifard) overnight at 4°C. The 
secondary antibodies were goat anti-mouse IgG Alexa Fluor488 (1:500; ThermoFisher; 
#A-11001) and goat anti-rabbit IgG Alexa Fluor488 (1:500; ThermoFisher; #A-11037). All 
blocking and antibody incubations were done in 3% BSA in TBST (0.05% Tween20). 
DAPI (ThermoFisher; #D3571) was used for nucleic acid staining. The spreads were 
mounted using Dako fluorescence mounting medium (Dako; #S3023) and imaged on a 
Leica DM6000 CS confocal microscope. For heat shock treatment, larvae were 
incubated for 5 min at 37°C.  
 
Reverse transcription quantitative PCR 
Total RNA from larvae, whole fly, fly heads, human cultured cells or human tissue was 
extracted using Trizol reagent (ThermoFisher; #15596026), following the manufacturer’s 
protocol. DNA was removed by Turbo DNA-free kit (ThermoFisher; #AM1907) for fly 
samples, RNeasy micro kit (QIAGEN; #74004) for human cultured cells or DNase I 
(ThermoFisher; #18068015) for human tissue samples. RNA quality was checked by gel 
or Agilent 2100 Bioanalyzer system (Agilent). Reverse transcription was performed with 
random hexamers using High-Capacity cDNA Reverse Transcription kit (ThermoFisher; 
#4368814) for samples from fly tissues and human cultured cells or SuperScript III 
Reverse Transcriptase (ThermoFisher; #18080093) for human tissue samples. Fast 
SYBR green master mix (ThermoFisher; #4385614) was used for qPCR performed by 
ViiA 7 Real-Time PCR system (ThermoFisher). Primers used for qPCR are listed in 
Supplementary Table 5, 6. Sequences of primers for CG6323, CG8408, CG16941, 
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CG11839, CG7892, CG13431, CG33108, CG16941 U12int and CG11839 U12int are as 
previously described 100.  
 
ChIP-Seq data analysis 
Raw fastq data from GSM345570 and GSM345568 (input control and Lilli ChIP-seq, 
respectively, were used to call Lilli peaks 69. Raw fastq data from GSM2224492 and 
GSM2224493 (input control replicates), GSM2224501 GSM2224502, GSM2224503, and 
GSM2224504 (TBPH ChIP-seq) were used to call narrow TBPH peaks 114.  Narrow 
peaks were called using the mosaics R package 141. Read trimming, alignment and peak 
calling steps were performed in R using a published pipeline 142. Software packages 
used were mosaics v2.12.0, Rbowtie v1.14.0, dada2 v1.2.2, quasR v 1.14.0, 
TxDb.Dmelanogaster.UCSC.dm6.ensGene v3.3.0, GenomicRanges v1.26.4, 
GenomicFeatures v1.26.4, BSgenome v1.42.0, biomaRt v2.30.0, AnnotationDbi v1.36.2, 
deeptools v3.1.0, python v2.7.10, Integrative Genomics Viewer v2.3.93, and R v3.3.2. 
Mosaics peaks were called using the default parameters, with the exceptions of analysis 
type IO, false discovery rate (FDR)=0.05. Only regions with a called mosaics narrow 
peak in all biological replicates, when compared to both controls, were counted as a 
peak. If these peaks lay within 250 bp of a transcription start site, the corresponding 
gene was considered to have a peak. 
 
Human cell culture 
The doxycycline-inducible (TetON) HEK293 cell lines, TetOn-GFP (clone#9.3) and 
TetOn-GFP-TDP-43 (clone#12.5) generated using a subclone of HEK293 cells (QBI-
293) are generous gifts from Dr. Virginia Lee’s laboratory. Cells were grown in 
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Dulbecco’s modified Eagle’s medium (DMEM) with L-glutamine, glucose and sodium 
pyruvate (Corning; #MT10013CV), supplemented with 10% Tet system approved FBS, 
1% penicillin/streptomycin. Media was further added 400 μg/ml G418 and 1 μg/ml 
puromycin. Cells were cultured at 37°C and 5% CO2 and routinely sub-cultured at 1:10 
ratio every 7 days. To induce expression, 1000 ng/ml doxycycline was added for 6 d. For 
heat shock treatment, cells were subjected to heat stress at 46°C followed by 6 hr 
recovery. Cells were checked for appropriate GFP-tagged protein expression.  
 
Human frontal cortical tissue 
Human postmortem brain samples were obtained from the University of Pennsylvania 
Center for Neurodegenerative Disease Brain Bank. All relevant ethical regulations were 
compiled, and informed consent from next of kin was obtained for all cases. These 
comprised samples from clinically normal individuals (n = 6), as well as individuals with 
FTLD-TDP (n = 13). The region sampled was midfrontal cortex (BA9), and all disease 
cases were previously reported and confirmed to have TDP-43 pathology 121,122. DNA 
was extracted from all cases and screened for mutations in the two most common genes 
associated with FTLD-TDP, GRN and C9orf72.  Briefly, the coding regions of GRN were 
bi-directionally sequenced by Sanger sequencing using flanking primers to each exon as 
previously described 143. Sequence analysis was done with Mutation Surveyor 
(SoftGenetics, State College, PA). Analysis for hexanucleotide repeat expansions in 
C9orf72 was performed using a modified repeat-primed PCR method 144. Analysis of the 
valosin containing protein gene (VCP) analysis was performed by targeted Sanger 
sequencing of the relevant exon in a case with known family history of a VCP mutation 
145. 
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Co-IP 
Endogenous Co-IP was performed by using the nuclear extract of HEK293 TetOn-GFP 
(clone#9.3) cells without doxycycline induction. Cells (~2.6*107) were resuspended in 
hypotonic solution (20 mM Tris-HCl (pH 7.5), 20 mM NaCl, 5 mM MgCl2) supplemented 
with protease inhibitor cocktail (Roche; #1183670001) and homogenized by Dounce 
homogenizer.  After centrifugation (3,000 g, 4°C, 15 min), the pellet containing nucleus 
was resuspended in Pierce IP lysis buffer (Thermo; #87787) supplemented with 
protease inhibitor cocktail (Roche; #1183670001). After centrifugation (15,000 g, 4°C, 
10 min), input sample was saved, and the rest of the lysate were divided to incubate 
at 4°C, overnight with Dynabeads Protein G (Invitrogen; #1004D) prepared with 5 µg 
of anti-TDP-43 mouse monoclonal antibody- mAb 5028146 (a generous gift from Dr. 
Virginia Lee’s lab) or same amount of mouse IgG control (Santa Cruz; #sc-2025). The 
next day, the beads were washed with lysis buffer 3 times, with the 3rd time rotating 
the tubes for 5 min in 4°C. Elute the proteins by NuPAGE LDS sample buffer 
(Invitrogen; #NP0007) by boiling at 95°C, 5min. The following western blotting were 
performed as described above. Experiments were repeated to confirm the results. 
 
Statistical analysis 
Graphs are represented as mean±standard deviation (SD). The statistics used are 
indicated in each figure legend. Comparison between two groups were calculated using 
the two-tailed unpaired Student’s t test. If data sets show significant variance according 
to variance F-test analysis, two-tailed unpaired Student’s t test with Welch’s correction 
was used as indicated in the figure legend. Shapiro-Wilk normality test was used for 
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testing normal distribution for all data sets except data sets normalized to 1. If the data 
are not normally distributed, two-tailed unpaired Mann-Whitney Test (nonparametric test) 
was used as indicated in the figure legend. The differences among three groups were 
calculated using ANOVA followed by Tukey’s multiple comparison test. Brown-Forsythe 
test and Shapiro-Wilk normality test were used to test variance differences and normality 
respectively for data analyzed by One-way ANOVA. Differences with P-values <0.05 
were considered statistically significant. The number of sample size and biological 
replicates is indicated in the methods section or figure legend. No statistical method was 
used to predetermine sample sizes. No sample was excluded from the analysis. No 
method of randomization was used. The investigators were not blinded to allocation 
during experiments.  
 
Data availability 
The data that support the findings of this study are available from the corresponding 
author upon reasonable request.  
 
Code availability 
The code used for analysis is available upon request. 
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Figures 
 
 
Figure 1. Components of LEC and SEC modulate TDP-43 toxicity 
(a) TDP-43 expression causes eye degeneration that is suppressed by Ell RNAi and 
enhanced by Ell upregulation. Scale bars: external eye images (top), 100 μm; internal 
retinal section (bottom), 5 μm. Genotypes: Control is gmr-GAL4(YH3)/+. gmr>TDP-43 is 
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UAS-TDP-43/+; gmr-GAL4(YH3)/+. gmr>TDP-43+Control RNAi is UAS-TDP-43/+; gmr-
GAL4(YH3)/UAS-Control.RNAiJF01355. gmr>TDP-43+Ell RNAi is UAS-TDP-43/+; gmr-
GAL4(YH3)/UAS-Ell.RNAiHMS00277. gmr>TDP-43+Ell is UAS-TDP-43/+; gmr-
GAL4(YH3)/UAS-EllP{EP}G4098.  
(b) Quantification of retina thickness related to Fig. 1a. Three flies of each genotypes 
were measured (n=3). Bars represent mean (SD). (**) P <0.01, (****) P<0.0001(Two-
tailed unpaired Student’s t test). Genotypes are the same as indicated in Fig. 1a. (A.U.) 
arbitrary units. 
(c) Schematic of LEC and SEC. 
(d) Downregulation of SEC components (ear and lilli), or LEC component (Ice1) 
suppresses TDP-43 toxicity. Scale bars: external eye (top), 100 μm; internal retina 
section (bottom), 5 μm. Genotypes: gmr>TDP-43 is UAS-TDP-43/+; gmr-GAL4(YH3)/+. 
gmr>TDP-43+ear RNAi is UAS-TDP-43/+; gmr-GAL4(YH3)/UAS-ear.RNAiHMS00107.  
gmr>TDP-43+lilli+/- is UAS-TDP-43/lilli17-2; gmr-GAL4(YH3)/+.  gmr>TDP-43+Ice1 RNAi 
is UAS-TDP-43/UAS-Ice1.RNAi (SH09112.N from DRSC/TRiP); gmr-GAL4(YH3)/+. 
(e) Quantification of retina thickness related to Fig 1d. Three flies of each genotypes 
were measured (n=3). Bars represent mean (SD). (**) P <0.01 (Two-tailed unpaired 
Student’s t test). Genotypes are the same as indicated in Fig. 1d. (A.U.) arbitrary units. 
(f) TDP-43 expression in the adult neurons by elavGS causes climbing defects. 
Knockdown of Ell restores climbing ability. RU486 (8 mg/ml) was used to induce the 
expression of TDP-43 and Ell RNAi. EtOH was used as vehicle. Total of 100 flies were 
measured 3 times for each genotype at different time points. Bars represent mean (SD). 
(***) P <0.001, (****) P<0.0001 (Two-way ANOVA followed by Tukey’s multiple 
comparison test). Significant differences are only indicated within the same time point. 
Genotypes: elavGS>TDP-43 is elavGS-GAL4, UAS-TDP-43/+. elavGS>TDP-43+Ell 
RNAi is elavGS-GAL4, UAS-TDP-43/UAS-Ell.RNAi HMS00277.  
(g) TDP-43 protein levels in heads from 7, 14 and 21d flies are not altered by Ell RNAi. 
n=3 biological replicates. Tubulin was used as internal control. Bars represent mean 
(SD). (NS) not significant (Two-tailed unpaired Student t test with Welch’s correction). 
Genotypes and RU486 treatment are as in Fig. 1f.   
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Figure 2. U12 snRNA is upregulated and a functional target of TDP-43  
(a) Northern blot analysis shows that the level of snRNAs U1, U4, U7 and U12 are 
upregulated by TDP-43 expression driven by a ubiquitous drug-inducible promoter, 
daGS, in heads. Ell RNAi corrects the increased levels of snRNAs. RU486 (4 mg/ml) 
was used to induce the expression of TDP-43 and Ell RNAi for 8d. 2S rRNA was the 
loading control. n=3 biological replicates. Bars represent mean (SD). (*) P <0.05, (**) P 
<0.01, (***) P <0.001, (****) P<0.0001 (One-way ANOVA followed by Tukey’s multiple 
comparison test). Genotypes: daGS>TDP-43 is daGS-GAL4/+; UAS-TDP-43/+. 
daGS>TDP-43+Ell RNAi is daGS-GAL4/+; UAS-TDP-43/UAS-Ell.RNAiHMS00277. 
(b) Knockdown of U12 suppresses eye degeneration caused by TDP-43 toxicity. Scale 
bars: external eye (top), 100 μm; internal retina (bottom), 5 μm. Genotypes: gmr>TDP-
43 is UAS-TDP-43/+; gmr-GAL4(YH3)/+.  gmr>TDP-43+U12 RNAi is UAS-TDP-43/ 
UAS-snRNA:U12:73B.RNAiHMC03841; gmr-GAL4(YH3)/+.  
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(c) Quantification of retina thickness related to Fig 2b. Three flies of each genotypes 
were measured (n=3). Bars represent mean (SD). (*) P <0.05 (Two-tailed unpaired 
Student’s t test). Genotypes are the same as indicated in Fig. 2b. (A.U.) arbitrary units. 
(d) Schematic illustrates detection of spliced or unspliced products by RT-qPCR for a 
U12-type intron. 
(e) RT-qPCR analysis shows that spliced products of CG15735, CG16941, CG11839 
are up-regulated by TDP-43 expression driven by daGS in fly heads, and 
downregulation of Ell rescues the increased levels, while the unspliced products are not 
changed significantly upon TDP-43 expression. RU486 (4 mg/ml) was used to induce 
expression for 8d. mRNA levels were normalized to RpL32 mRNA. n=6 biological 
replicates. Bars represent mean (SD). (*) P <0.05, (****) P<0.0001 (One-way ANOVA 
followed by Tukey’s multiple comparison test). Genotypes are as indicated in Fig. 2a. 
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Figure 3. TDP-43 and Lilli co-localize at the 93D locus on polytene chromosomes  
(a) Immunostainings of DAPI (white), TDP-43-YFP (green) and Lilli (magenta) show 
partial overlap of TDP-43-YFP and Lilli on chromosomes from salivary glands 
expressing TDP-43-YFP. Sixteen sites of consistent co-localization are indicated 
(bottom, see also Supplementary Table 1).  
(b) Upon heat shock, Lilli localizes to major heat shock loci and co-localizes with TDP-
43-YFP at the 93D locus (enlarged at the upper right corner). See also Supplementary 
Table 2. 
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For (a) and (b), scale bars: 10 μm. Genotype: sgs3-GAL4/UAS-TDP-43-YFP. 
(c) Venn diagram illustrates the numbers of genes bound by TBPH and Lilli. 
(d) A ChIP-seq profile of TBPH (top, blue) and Lilli (bottom, orange) shows overlap at 
the Hsrω transcription start site. Bar intervals indicate called peaks in TBPH (light blue, 
top) and Lilli (light orange, bottom). The TBPH profile is one of four biological replicates 
that show called peaks at Hsrω transcription start site. 
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Figure 4. Hsrω is elevated and contributes to TDP-43 toxicity 
(a) RT-qPCR analysis of fly heads shows that expression of TDP-43 driven by a drug-
inducible promoter daGS leads to an increase of total Hsrω and Hsrω-n. Knockdown of 
Ell reduces the elevated levels of total Hsrω and Hsrω-n. RU486 (4 mg/ml) was used to 
induce expression for 4d. Relative RNA levels were normalized to Pgk, RpL32 and 
RpS20 mRNAs (geometric mean). n=3 biological replicates. Bars represent mean (SD). 
(*) P <0.05, (**) P <0.01, (***) P <0.001 (One-way ANOVA followed by Tukey’s multiple 
comparison test). Genotype: daGS>TDP-43 is daGS-GAL4/+; UAS-TDP-43/+. 
daGS>TDP-43+Ell RNAi is daGS-GAL4/+; UAS-TDP-43/UAS-Ell.RNAiHMS00277. 
(b) Images of external eyes (top) and internal retina (bottom) show that loss of one copy 
of Hsrω ameliorates TDP-43-caused eye degeneration. Scale bars: external eye, 100 
μm; internal retina section, 5 μm. Genotypes: gmr>TDP-43 is UAS-TDP-43/+; gmr-
GAL4(YH3)/+. gmr>TDP-43+Hsrω+/- is UAS-TDP-43/+; gmr-GAL4(YH3)/Hsrω66. 
(c) Quantification of retina thickness related to Fig 4b. Three flies of each genotypes 
were measured (n=3). Bars represent mean (SD). (**) P <0.01 (Two-tailed unpaired 
Student’s t test). Genotypes are the same as indicated in Fig. 4b. (A.U.) arbitrary units. 
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Figure 5. Sat III is upregulated in a human cell model and FTD patient samples 
(a) RT-qPCR analysis shows that the levels of Sat III are increased in HEK293 cells 
expressing GFP-TDP-43 after 6d induction. Relative RNA levels were normalized to 
GAPDH and ACTB mRNAs (geometric mean). n=6 biological replicates. Bars represent 
mean (SD). (****) P<0.0001 (Two-tailed unpaired Student’s t test with Welch’s 
correction).  
(b) RT-qPCR analysis shows that the levels of Sat III are increased significantly in frontal 
cortex of FTD patients compared to normal frontal cortex controls. Relative RNA levels 
were normalized to GAPDH and ACTB mRNAs (geometric mean). All FTD patients had 
TDP-43 pathology (FTLD-TDP). Case numbers and details are as indicated in Table 1. 
Bars represent mean (SD). (**) P<0.01 (Two-tailed unpaired Student’s t test with Welch’s 
correction). 
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Figure 6. TDP-43 interacts with ELL2 in human cells 
(a) RT-qPCR analysis of fly heads shows that expression of TDP-43 driven by daGS 
leads to an increase of Ell. RU486 (4 mg/ml) was used to induce expression for 4d. 
Relative RNA levels were normalized to Pgk, RpL32 and RpS20 mRNAs (geometric 
mean). n=3 biological replicates. Bars represent mean (SD). (**) P <0.01 (Two-tailed 
unpaired Student’s t test). Genotypes are the same as indicated in Fig. 4a.  
(b) RT-qPCR analysis shows that the levels of ELL and ELL2 are increased in HEK293 
cells expressing GFP-TDP-43 compared to cells expressing GFP after 6d induction. 
Relative RNA levels were normalized to GAPDH and ACTB mRNAs (geometric mean). 
n=6 biological replicates. Bars represent mean (SD). (****) P<0.0001 (Two-tailed 
unpaired Student’s t test). 
(c) IP with anti-TDP-43 antibody or mouse IgG as negative control followed by 
immunoblotting studies with anti-ELL, ELL2 or TDP-43 antibody show that TDP-43 
interacts with ELL2. The co-IP assays were repeated independently four times and show 
consistent results (a different ELL2 antibody was used for detection for two repeats of 
the experiments).  
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Figure 7. TDP-43 promotes the levels of the targets of LEC and SEC contributing 
to neurodegeneration 
A model for TDP-43 toxicity associated with LEC and SEC.  LEC regulates the 
transcription of snRNAs, forming spliceosomes, and SEC regulates stress response 
genes, maintaining cell homeostasis. In the disease state, TDP-43 promotes the levels 
of LEC and SEC targets through interactions with Ell in fly/ELL2 in human cells, 
including U12 and Hsrω/Sat III, leading to misregulation of splicing, cell loss and 
disruption of cell homeostasis and contributes to neurodegeneration. 
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Tables 
Table 1. Human brain samples 
  Number 
Normal controls No mutation identified 6 
FTD 
(FTLD-TDP) 
No mutation identified 6 
GRN mutation 5 
C9Orf72 mutation 1 
VCP mutation 1 
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Supplementary Information  
Supplementary Table 1. Quantification of co-localization of TDP-43-YFP and Lilli 
on 16 sites in 4 polytenes, related to Figure 3.  
 
Chromosome ~Cytological bands Polytene 1 Polytene 2 Polytene 3 Polytene 4 
X 
2E + + + + 
3F + ? + + 
15C + + + + 
17C + + + + 
18B + + + + 
2L      
2R 
43E + + + + 
48A + + + + 
60A/B + + + + 
3L 
61C + + + + 
62A + + ? + 
74 EF + (weak) + + + 
75CD + (weak) + + (weak) + 
3R 
82D + + + + 
93D + + + + 
95F + + + + 
100C + + + + 
 
(+) co-localization, (?) unable to define due to pattern of chromosome spreading.  
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Supplementary Table 2. Quantification of co-localization of TDP-43-YFP and Lilli 
on 6 major heat shock loci in 15 polytenes, related to Figure 3.  
 
Major heat shock loci 63B 67B 93D 95D 87A 87C 
Polytene 1 + (weak) + (weak) + - - - 
Polytene 2 - + + - - - 
Polytene 3 + (weak) - + - - - 
Polytene 4 + (very week) + (weak) + - - - 
Polytene 5 + (weak) - + - - - 
Polytene 6 + (weak) - + - - - 
Polytene 7 + (weak) - + - - - 
Polytene 8 - - + (weak) - - - 
Polytene 9 - - + - - - 
Polytene 10 + - + - - - 
Polytene 11 + (very weak) - + - - - 
Polytene 12 + (very weak) - + - - - 
Polytene 13 - - + - - - 
Polytene 14 - - + - - - 
Polytene 15 - - + - - - 
 
(+) co-localization, (-) no co-localization.  
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Supplementary Table 3. Fly lines.  
 
 
Bloomington is to the Bloomington Drosophila Stock Center, https://bdsc.indiana.edu/ 
  
Fly lines Insertion chromosome(s) Reference/Source 
w1118  1 Bloomington 
UAS-TDP-43-YFP 3 37 
UAS-TDP-43 2 37 
UAS-TDP-43 3 37 
elavGS-GAL4 3 Bloomington 
daGS-GAL4 2 140 
da-GAL4 3 Bloomington 
gmr-GAL4(YH3) 3 37 
sgs3-GAL4 3 Bloomington 
UAS-LacZ 2 Bloomington 
lilli17-2 2 Bloomington 
Hsrω66 3 Bloomington 
UAS-EllP{EP}G4098 3 Bloomington 
UAS-Ell.RNAiHMS00277 3 Bloomington 
Ell[S-192] 3 Bloomington 
UAS-ear.RNAiHMS00107 3 Bloomington 
UAS-Ice1.RNAi (SH09112.N from DRSC/TRiP) 2 This paper 
UAS-Ice1.RNAi (SH09113.N from DRSC/TRiP) 3 This paper 
UAS-Ice1.RNAi (13550R-2 from NIG) 2 NIG 
UAS-snRNA:U12:73B.RNAiHMC03841 2 Bloomington 
UAS- Hsrω.RNAiHMC05093 2 Bloomington 
UAS-Control.RNAiJF01355 3 Bloomington 
UAS-(G4C2)48 2 147 
UAS-mCherry RNAi 2 Bloomington 
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Supplementary Table 4. Probes for small RNA Northern blot.  
 
Name Sequence 
U1 5′-GATAATACGACTCACTATAGGGAGA-3′ 5’-AAAAAACTGAGTTGACCTCTGCGATTATTCCTCTCCCTATAGTGAGTCGTATTATC-3′ 
U2 5′-GATAATACGACTCACTATAGGGAGA-3′ 5’-AAAAAATCGGCCTTATGGCTAAGATCAAATCTCCCTATAGTGAGTCGTATTATC-3′ 
U4 5′-GATAATACGACTCACTATAGGGAGA-3′ AAAAAAGAAAACTTTAACCAATACCCCGCCTCTCCCTATAGTGAGTCGTATTATC-3′ 
U4atac 5′-GATAATACGACTCACTATAGGGAGA-3′ 5’-AAAAAATCAATGAACGTCTAGTGAGGACATTTCTCCCTATAGTGAGTCGTATTATC-3′ 
U5 5′-GATAATACGACTCACTATAGGGAGA-3′ 5’-AAAAAATCTGGTTTCTCTTCAATTGTCGAATTCTCCCTATAGTGAGTCGTATTATC-3′ 
U7 5′-GATAATACGACTCACTATAGGGAGA-3′ 5’-AAAAAACTCTTTGAAATTTGTCTTGGTGGGATCTCCCTATAGTGAGTCGTATTATC-3′ 
U11 5′-GATAATACGACTCACTATAGGGAGA-3′ 5’-AAAAAAGTTTCCGATCACGAAACTCAAGTGTCTCCCTATAGTGAGTCGTATTATC-3′ 
U12 5′-GATAATACGACTCACTATAGGGAGA-3′ 5’-AAAAAAAATGAGTAAGGAAAACCAATCAGCCTCTCCCTATAGTGAGTCGTATTATC-3′ 
2S 5′-GATAATACGACTCACTATAGGGAGA-3′ 5’-TGCTTGACTACATATGGTTGAGGGTTGTATCTCCCTATAGTGAGTCGTATTATC-3′ 
 
Two DNA oligonucleotides were annealed to obtain the template for each RNA probe.   
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Supplementary Table 5. qPCR primers for Drosophila genes.  
 
Name Forward Sequences (5’-3’) Reverse Sequences (5’-3’) 
Ell AAAACAAACTCACATACAACCAAAAA GCACTCGTTGTGGAAGTAGACA 
Ear TTCCGAAACCCAAACGAGT CGTCTCGGTTGCGAAAGTA 
Ice1 ACCACTTCCAGCCCTATGAG GCTTCCCCACCAGGTTCT 
U12 TTTGCAAGGGCACAGGTC GCTAGCCGGACGCAAAGTAG 
CG6323 TGCTCTTCTTCTACATGATCATTCTGTT GCACTTGTTTGCGCAAATCC 
CG8408 GTCGCCTACGTATTCCTGCAAACA CCAGCGCCGAACAGAAACATATGA 
CG16941 GCCGGAAGTTAGAAATATCGTTGAC ACTTTGGATTGCCCAGCTCA 
CG11839 CACCATTGGCAAAGTATGACTCCTCG CCACCTTATTCTGCTTAGCCTGATCG 
CG7892 CTTTCAAGAAATCTATGTGATAACGGAG GGATCTGGTACAGGAACACCTT 
CG13431 ATGGCCCAAATCCTTCTGGGATGA CCAAACGTGCGAGTGCGTGATATT 
CG33108 GCCTACTAGTGCCCTACGATG TGCGTGTCCACCAGATAACCTA 
CG7736 CCTCGAGGACACTATCAGCA CCTTCATCTGCTTGACCTCATC 
CG17912 CCTCCAAACCCTGGTGCT GGGTCCGGTGTACAACTTCTT 
CG32705 CGCCCATCGTAGCCATTATC CATGTGGAAGCCGGTCAGT 
CG11328 CGTTGAGCGATTTCTTCTCC TCGAACCCGAGTAAATTTGG 
CG17228 TGACGGCATGGCTCCTAC GGGATAGCGCACCCAGAA 
CG15081 AGAAGCCGAGGCTGCTAA TGCGTGCAATGCTTTGAG 
CG11984 GCGAGCCGAATCTAGTCACA GATGCGACGCACTCCAC 
CG4894 ATTCGCATTGTGGAGTGG GTAAACAGCCAAGGCAATACAG 
CG18177 GGCAAGGACGGATTCACCT CATCGACGCGTAGTGCTTG 
CG15735 GGCCTTCGATCACAACACA GTTGCCGTTGCACTCCTT 
CG3294 GAACTGCATGCCAAGAGG GGTGTACTCCAGTTCCGTGT 
CG16941 U12int ATGGCAACTTTAGACGCGGAA TTGTTTTCTTTTTGGCAAAGGATGC 
CG11839 U12int GTTGTTTACACTTTCTAGCCGGTGT GCCCGAGGAGTCATACGTATAGTTA 
CG33108 U12int GCATGTAGGTCCTTTGGACTG CAGTGTGCTGTTCACCGTTTAC 
CG11328 U12int TAACTCCCACCGCACATGA GGCCACCACACCAGTAAGTT 
CG15735 U12int GGCCTTCGATCACAACACA AGAAAGTGCTCGCTTTCACC 
CG3294 U12int GCGGTACGTGAACTGCAT CAGTCGTTACCTTTGGGACA 
Hsrω-all TATCTAATGTCCGGGGTCGT CACAATCCGCACAATCAATC 
Hsrω-n ATAGTCCCTCGGAGGAAAGG GCGCTCACAGGAGATCAA 
βTub56D CATCCAAGCTGGTCAGTG  GCCA TGCTCATCGGAGAT  
Pgk ATCACCAGCAACCAGAGAATTG TGCCAGGGTGTACTTGATGTT 
RpS20 CCGCATCACCCTGACATCC TGGTGATGCGAAGGGTCTTG 
RpL32 CATCCGCCCAGCATACAG CCATTTGTGCGACAGCTTAG 
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Supplementary Table 6. qPCR primers for human genes.  
 
Name Forward Sequences (5’-3’) Reverse Sequences (5’-3’) 
Sat III GTGCAATCGAATGGAATCG CCATTCCTGTACTCGGGTTG 
GAPDH CGAGATCCCTCCAAAATCAA TTCACACCCATGACGAACAT 
ACTB TTCCTGGGCATGGAGTC CAGGTCTTTGCGGATGTC 
ELL GTCGGAGACGCCTGACTACT TACTCGGCATTGAAGTCGTTC 
ELL2 TGGGAGCAATTCTGCAAC ATCCAGGCCAGTCTCTTTGA 
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Supplementary Figure 1. Downregulation of components in SEC and LEC 
suppresses TDP-43-caused degeneration  
 
(a) RT-qPCR analysis verifies that Ell, ear and Ice1 are knocked down by RNAi and Ell 
is elevated by the upregulation fly line. RU486 (4 mg/ml) was used to induce the 
expression of RNAi driven by daGS promoter. Whole flies were used for accessing 
knockdown effects of Ell RNAi and Ice1 RNAi (8d RU486 induction), and upregulation 
effect of Ell (1d). Larvae were collect for evaluate ear RNAi effect. Relative mRNA levels 
were normalized to βTub56D mRNA. n=3 biological replicates. Bars represent mean 
(SD). (**) P <0.01, (***) P <0.001 (Two-tailed unpaired Student’s t test with Welch’s 
correction for RNAi effect; Two-tailed unpaired Student’s t test for upregulation effect of 
Ell). Genotype: daGS>Ell RNAi is daGS-GAL4/+; UAS-Ell.RNAiHMS00277/+, Control for Ell 
is da-GAL4/+, da>Ell is da-GAL4/UAS- EllP{EP}G4098, Control for ear is da-GAL4/mCherry 
RNAi, da>ear RNAi is da-GAL4/UAS-ear.RNAiHMS00107, daGS>Ice1 RNAi is daGS-
GAL4/UAS-Ice1.RNAi (SH09112.N from DRSC/TRiP).  
(b) Reduction of components involved in SEC and/or LEC on their own does not affect 
eye integrity. Scale bars: 100 μm. Genotype: Control is gmr-GAL4(YH3)/+, gmr>Ell RNAi 
is gmr-GAL4(YH3)/UAS-Ell.RNAiHMS00277, gmr>Ell is gmr-GAL4(YH3)/UAS-EllEPG4098, 
gmr>ear RNAi is gmr-GAL4(YH3)/UAS-ear.RNAiHMS00107, lilli+/- is lilli17-2/+; gmr-
GAL4(YH3)/+ and gmr>Ice1 RNAi is UAS-Ice1.RNAi (SH09112.N from DRSC/TRiP)/+; 
gmr-GAL4(YH3)/+. 
(c) The levels of TDP-43 are unaltered by Ell RNAi, ear RNAi, loss a genomic copy of lilli 
or upregulation of Ell. The levels of TDP-43 are elevated by Ice1 RNAi. n=3 biological 
replicates. Bars represent mean (SD). (NS) not significant, (**) P <0.01 (Two-tailed 
unpaired Student’s t test). Genotypes of the flies are the same as indicated in Fig. 1a, d. 
(d) Western blot analysis of β-gal shows that the GAL4/UAS system is not altered by 
downregulation of components in SEC and/or LEC. n=3 biological replicates. Bars 
represent mean (SD). (NS) not significant (Two-tailed unpaired Student’s t test). 
Genotypes: gmr>β-gal; Control is gmr-GAL4, UAS-β-gal/+, gmr>β-gal+Ell RNAi is gmr-
GAL4, UAS-β-gal/+; UAS-Ell.RNAiHMS00277/+, gmr> β-gal+ear RNAi is gmr-GAL4, UAS-β-
gal/+; UAS-ear.RNAiHMS00107/+, gmr> β-gal+lilli+/- is gmr-GAL4, UAS-β-gal/lilli17-2, gmr> 
β-gal+Ice1 RNAi is gmr-GAL4, UAS-β-gal/UAS-Ice1.RNAi (SH09112.N from 
DRSC/TRiP). 
(e) Depletion of Ell and Ice1 by additional fly lines show the suppression effect on TDP-
43-mediated eye degeneration. The levels of TDP-43 and RNAi effect were confirmed by 
western blotting and RT-qPCR. For RNAi effect confirmation, RU486 (4 mg/ml) was 
used to induce the expression of RNAi driven by daGS promoter for 8 days. Genotypes: 
gmr>TDP-43 is UAS-TDP-43/+; gmr-GAL4(YH3)/+. gmr>TDP-43+Ell+/- is UAS-TDP-
43/+; gmr-GAL4(YH3)/Ell[S-192].  gmr>TDP-43+Ice1 RNAi(NIG) is UAS-TDP-43/UAS-
Ice1.RNAi (13550R-2 from NIG); gmr-GAL4(YH3)/+.  gmr>TDP-43+Ice1 RNAi(TRiP) is 
UAS-TDP-43/+; gmr-GAL4(YH3)/UAS-Ice1.RNAi (SH09113.N from DRSC/TRiP). 
daGS>Ice1 RNAi(NIG) is daGS-GAL4/UAS-Ice1.RNAi (13550R-2 from NIG) and 
daGS>Ice1 RNAi(TRiP) is daGS-GAL4/+; UAS-Ice1.RNAi (SH09113.N from 
DRSC/TRiP)/+. 
 (f) TDP-43 expression in the adult neurons by elavGS causes climbing defects, which 
can be rescued by knockdown of Ell. Genotypes are as indicated in Fig. 1f.  
(g) Knockdown of Ell on its own in neurons causes no climbing defects. Genotypes: 
elavGS>Ell RNAi is elavGS-GAL4, UAS-Ell.RNAi HMS00277/+.  
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For (f) and (g), RU486 (4 mg/ml) was used to induce the expression of TDP-43 and Ell 
RNAi. EtOH was used as vehicle. 100 flies were measured 3 times for each genotype at 
different time points. Bars represent mean (SD). (*) P <0.05, (**) P <0.01, (***) P <0.001, 
(****) P<0.0001, (NS) not significant (Two-way ANOVA followed by Tukey’s multiple 
comparison test). Significant differences are only indicated within the same time point. 
(h) (I) Lifespan analysis of flies expressing TDP-43 and/or Ell RNAi by neuronal driver 
elavGS (h) or ubiquitous driver daGS (I) show that Ell depletion mildly prolongs the 
lifespan on its own and mildly extends the shortened lifespan mediated by TDP-43 
expression. Genotypes are as indicated in Fig. 1f and Fig. 2a. n=200 flies per group. P 
values are indicated in the figure (Log-rank test and Gehan-Breslow-Wilcoxon test). 
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Supplementary Figure 2. Expression of TDP-43 affects the levels of selected 
snRNAs and U12 intron-containing genes in fly heads  
 
(a) Western blot analysis shows that downregulation of Ell does not alter TDP-43 protein 
levels driven by ubiquitous drug-inducible diver daGS in fly heads. Genotypes of the flies 
and RU486 treatment are the same as indicated in Fig. 2a, e. 
(b) Northern blot analysis of Pol II-transcribed snRNAs shows that U2, U4atac, U5 and 
U11 are not significantly affected by TDP-43 expression in fly heads. 2S rRNA was the 
internal control. Genotypes of the flies and RU486 treatment are the same as indicated 
in Fig. 2a, e. 
(c) RT-qPCR analysis verifies that U12 is knocked down by RNAi. RU486 (4 mg/ml) was 
used to induce the expression of RNAi for 8d, and whole flies were used. Relative 
mRNA levels were normalized to RpL32 mRNA. Genotype: daGS>U12 RNAi is daGS-
GAL4/UAS-snRNA:U12:73B.RNAiHMC03841. 
(d) Western blot analysis confirms that the levels of TDP-43 protein are not altered by 
U12 RNAi. Genotypes of the flies are the same as indicated in Fig. 2b. 
(e) Knockdown of U12 on its own does not affect eye integrity. Scale bars: 100 μm. 
Genotype: Control is gmr-GAL4(YH3)/+ and gmr>U12 RNAi is UAS- 
snRNA:U12:73B.RNAiHMC03841/+; gmr-GAL4(YH3)/+.  
(f) RT-qPCR analysis of U12 intron-containing genes shows that 12 out of 18 genes are 
not altered by TDP-43 expression in fly heads. Relative mRNA levels were normalized to 
RpL32 mRNA. Genotypes of the flies and RU486 treatment are the same as indicated in 
Fig. 2a, e. 
For (a-d) and (f), n=3 biological replicates. Bars represent mean (SD). (*) P <0.05, (**) P 
<0.01, (***) P <0.001, (NS) not significant (Two-tailed unpaired Student t test for 
comparisons between 2 groups; One-way ANOVA followed by Tukey’s multiple 
comparison test for comparisons among 3 groups).  
(g) RT-qPCR analysis of 18 genes regulated by U12-dependent spliceosome shows that 
both the spliced and unspliced products of CG33108, CG11328, CG3294 are up-
regulated by TDP-43 expression driven by daGS in fly heads, and downregulation of Ell 
rescues the increased levels. RU486 (4 mg/ml) was used to induce expression for 8d. 
mRNA levels were normalized to RpL32 mRNA. Statistical analysis and genotypes are 
as indicated in Fig. 2a,e.   
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Supplementary Figure 3. TDP-43 and Ell co-localize at the 93D locus on polytene 
chromosomes 
 
Immunostainings of DAPI (white), TDP-43-YFP (green) and Ell (magenta) show partial 
overlap and co-localization of TDP-43-YFP and Ell on Hsrω locus in salivary glands 
expressing TDP-43-YFP. Scale bars: 10 μm. Genotype is as indicated in Fig. 3a, b.  
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Supplementary Figure 4. Controls for the specificity of Hsrω on TDP-43 toxicity 
 
(a) Western blot analysis confirms that the levels of TDP-43 are not altered by 
downregulation of Hsrω. n=3 biological replicates. Bars represent mean (SD). (NS) not 
significant (Two-tailed unpaired Student t test). Genotypes are as indicated in Fig. 4b. 
(b) Loss of one copy of Hsrω does not disrupt eye integrity. Scale bars: 100 μm. 
Genotype: Control is gmr-GAL4(YH3)/+ and Hsrω+/- is gmr-GAL4(YH3)/Hsrω66. 
(c) Depletion of Hsrω by an RNAi fly line suppresses the eye degeneration caused by 
TDP-43 expression. The levels of TDP-43 and RNAi effect were confirmed by western 
blotting and RT-qPCR. For RNAi effect confirmation, RU486 (4 mg/ml) was used to 
induce the expression of RNAi driven by daGS promoter for 8 days, and whole flies were 
used. Genotypes: gmr>TDP-43 is UAS-TDP-43/+; gmr-GAL4(YH3)/+. gmr>TDP-
43+Hsrω RNAi is UAS-TDP-43/UAS-Hsrω.RNAiHMC05093; gmr-GAL4(YH3)/+. daGS>Hsrω 
RNAi is daGS-GAL4/UAS-Hsrω.RNAiHMC05093.  
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Supplementary Figure 5. Sat III qPCR primers detect a large-fold induction by heat 
stress 
 
RT-qPCR analysis shows that the levels of Sat III are dramatically induced by heat 
stress in HEK293 cells expressing GFP after 6d induction. Relative RNA levels were 
normalized to GAPDH and ACTB mRNAs (geometric mean). n=6 replicates. Bars 
represent mean (SD). (**) P<0.01 (Two-tailed unpaired Student’s t test with Welch’s 
correction).  
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Supplementary Figure 6. RNA levels and protein levels of ELL and ELL2 are not 
altered in patient samples and a HEK293 cell disease model respectively 
 
(a) RT-qPCR analysis shows that the levels of ELL and ELL2 are increased significantly 
in frontal cortex of FTLD-TDP compared to normal frontal cortex controls. Bars represent 
mean (SD). (NS) not significant (Two-tailed unpaired Student’s t test and Two-tailed 
unpaired Mann-Whitney test for ELL; Two-tailed unpaired Student’s t test for ELL2). 
Sample details are as indicated in Fig. 6b. 
(b) Western blot analysis of ELL and ELL2 show that protein levels of ELL and ELL2 are 
not altered in HEK293 cells expressing GFP-TDP-43 compared to cells expressing GFP 
after 6d induction. GAPDH was used as internal control. n=4 biological replicates. Bars 
represent mean (SD). (NS) not significant (Two-tailed unpaired Student t test). 
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Supplementary Figure 7. The uncropped scans of western blots in Fig. 1g and Fig. 
6c 
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Supplementary Figure 8. The uncropped scans of small RNA Northern blots 
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Supplementary Figure 9. Depletion of Ell suppresses the eye degeneration caused 
by G4C2 expansion 
 
Expression of GGGGCC expansion causes eye degeneration, which is suppressed by 
Ell RNAi. Scale bars: 100 μm. Genotypes: Control is gmr-GAL4(YH3)/+. gmr>(G4C2)48 is 
UAS-(G4C2)48/+; gmr-GAL4(YH3)/+. gmr>(G4C2)48+Control RNAi is UAS-(G4C2)48/+; gmr-
GAL4(YH3)/UAS-Control.RNAiJF01355. gmr>(G4C2)48+Ell RNAi is UAS-(G4C2)48/+; gmr-
GAL4(YH3)/UAS-Ell.RNAiHMS00277. 
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Supplementary Data  
File Name: Supplementary Data 1  
Description: The lists of genes bound by TBPH, Lilli or both, derived from 69,114 
(The file will be able to be downloaded from https://www.nature.com/ncomms/) 
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CHAPTER 3: CONCLUSION AND FUTURE DIRECTIONS 
CONCLUSION OF THE FINDINGS AND OPEN QUESTIONS  
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Conclusions  
Our work defined Ell, the shared subunit of LEC and SEC, as a strong dose-dependent 
modifier of TDP-43-mediated degeneration by using a powerful Drosophila disease 
model expressing human TDP-43 in the fly eye system (Figure 1a-c). The identification 
of Ell was through a fly genetic screen for modifiers of TDP-43-mediated eye 
degeneration. Other potential modifiers of TDP-43 toxicity indicated by the screen are 
listed in Table 3.1 (derived from Ross Weber’s data). Depletion of the components 
specific for LEC or SEC partially suppressed the eye degeneration, although the 
suppression is not as strong as downregulation of the shared component Ell (Figure 
1d,e). The ability to suppress TDP-43-mediated neurodegeneration was further 
demonstrated in the fly nervous system (Figure 1f). These findings reveal the important 
roles of Ell and Ell-containing complexes in TDP-43-mediated neurodegeneration, and 
implicate misregulation of LEC and SEC in mechanisms of disease.  
 
We sought evidence indicating that the activities of LEC and SEC were upregulated. By 
Northern blot analysis, several LEC target snRNAs, including U1, U4, U7 and U12 
snRNAs, were upregulated in fly heads with TDP-43 expression compared to controls 
(Figure 2-2a). Among these, depletion of U12 snRNA functionally ameliorated eye 
degeneration caused by TDP-43, indicating that the elevation of U12 contributes to TDP-
43-mediated degeneration (Figure 2b,c). Further examination of the levels of 18 genes 
containing an intron regulated by the U12-dependent spliceosome showed that the 
spliced products of 3 genes, CG15735, CG16941 and CG11839, are upregulated in fly 
heads with expression of TDP-43, with the levels of the unspliced products unchanged 
(Figure 2e). These results suggest that the activity of LEC might be upregulated, leading  
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Table 3-1. Additional potential modifiers of TDP-43 toxicity 
Gene Symbol Gene (CG #) Bloomington Stock # Effect 
E(bx) CG32346 27471 Enhancer 
pcm CG3291 33263 Enhancer 
SREBP CG8522 27232 Suppressor 
CG3542 CG3542 17291 Suppressor 
CG7220 CG7220 29681 Suppressor 
CG44837  CG44837  17283 Suppressor 
CG16711 CG16711 27182 Suppressor 
CG17187 CG17187 30066 Suppressor 
Mnt; Parg CG13316; CG2864 10086 Suppressor 
CG5009 CG5009 148 (P{EP}CG5009B227.2) Suppressor 
Smyd5  CG3353 30047 Suppressor 
bin3 CG8276 22584 Suppressor 
RpS15 CG8332 27125 Suppressor 
Ac76E CG7978 17485 Suppressor 
Top3α CG10123 17238 Suppressor 
Vha68-2 CG3762 17243 Suppressor 
Vamp7 CG1599 28488 Suppressor 
ppk5; Rpn10 CG33289; CG7619 27212 Suppressor 
CG14182 CG14182 27134 Suppressor 
CG6923 CG6923 30077 Suppressor 
Hph CG44015 20142 Lethal 
fus CG8205 27457 Lethal 
CG11110 CG11110 27466 Lethal 
CG7530 CG7530 15762 Lethal 
CG5789 CG5789 17083 Lethal 
CG15771; lin-52 CG15771; CG15929 17004 Lethal 
S6KL; CG6961 CG7001; CG6961 10144 Lethal 
CG6294; CG6299 CG6294; CG6299 33456 Lethal 
RpI12; tsl CG13418; CG6705 32613 Lethal 
 
(The table is derived from Ross Weber’s data) 
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to downstream abnormally elevated activity of the U12-dependent spliceosome, 
contributing to TDP-43 toxicity. 
 
A different approach was undertaken to define important targets of SEC. By Drosophila 
polytene chromosome immunostaining under ambient and heat shock treatment, TDP-
43 and Lilli (the essential component of SEC) were discovered to colocalize on the 
chromosomal locus of a stress-induced lncRNA Hsr⍵, suggesting that Hsr⍵ is a shared 
target of TDP-43 and SEC (Figure 3a,b). Analyses of published ChIP-seq databases of 
fly TBPH and Lilli 69,114 also showed that Hsr⍵ is a gene bound by both factors (Figure 
3c,d). The levels of Hsr⍵ are increased in the fly disease model and Hsr⍵ was shown to 
functionally contribute to TDP-43-mediated degeneration (Figure 4a-c). These data show 
that TDP-43 co-localizes with central SEC components on the chromosomes, identifying 
a novel non-coding lncRNA target of TDP-43 with functional importance to degeneration.  
 
Our results suggest a model in which SEC and LEC contribute to TDP-43-meidated 
degeneration in parallel. By comparing the retinal thickness in the fly disease model, 
downregulation of the shared component Ell restored eye degeneration caused by TDP-
43 and caused a 4-fold increase in retinal thickness that was comparable to normal 
retinal thickness. By contrast, depletion of LEC- and SEC-specific components led to 
only a ~2-fold increase in retinal thickness, and depletion of downstream targets U12 
and Hsr⍵ led to only ~1.5-fold increase in retinal thickness. Comparison of the retinal 
thickness is shown in Figure. 3.1. 
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The relevance of this stress-induced lncRNA in human disease was further assessed 
using a human cell disease model and patient tissue. The levels of the human 
counterpart of Hsr⍵, Sat III, in HEK cells expressing GFP-tagged TDP-43 was 
upregulated ~4-fold compared to control (Figure 5a). Furthermore, the levels of Sat III 
were increased significantly in frontal cortical tissues from FTD patients with TDP-43 
pathology (FTLD-TDP) compared to tissue from normal individuals (Figure 5b).  Since 
upregulation of Sat III has been shown to promote cell death and acute senescence in 
different cell models 119,120, these results suggest that stress-induced non-coding RNA 
Sat III may be a contributor to TDP-43-mediated degeneration. 
 
Given that ELL is the shared element of LEC and SEC, we sought to define how 
disruption of ELL function may be induced by TDP-43.  We found that TDP-43 physically 
interacts one of the ELL orthologues in HEK293 cells by co-immunoprecipitation. We 
were able to test ELL and ELL2, and found evidence that TDP-43 interacts in lysates 
with human ELL2 (Figure 6c). Together with the immunostaining data showing that TDP-
43 co-localizes with SEC on polytene chromosomes, these results indicate that a 
Figure 3-1. Comparison of suppression 
effects of downregulation of different factors 
Analysis of retinal thickness shows that depletion 
of the shared component Ell suppresses TDP-43-
mediated eye degeneration more strongly than 
downregulation of LEC- or SEC-specific 
components, or downstream targets.  
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mechanism contributing to the promotion of LEC and SEC activity may include 
interaction between TDP-43 and the proteins of the complexes. 
 
These findings reveal novel roles of the transcription elongation factor Ell-containing 
complexes, highlight the importance of non-coding RNAs in disease, elucidate new 
mechanistic insight into neurodegenerative disorders and provide therapeutic targets for 
TDP-43-associated neurodegeneration. 
 
Future directions 
Targets of LEC and SEC 
In the investigation of the targets of LEC and SEC, we used information from the 
literature to define potential important targets and used different assays to examine the 
role of these potential targets. Through these approaches, we identified important 
targets, including U12 snRNA and Hsrw, that we showed are functionally involved in 
TDP-43-mediated degeneration (Figure 2, 3 and 4). The relationship and interaction 
between U12 and Hsrw in suppressing TDP-43 toxicity can be further dissected. One 
interesting question is whether downregulation of one of these targets can affect the 
levels of the other. This can be addressed by assessing the levels of U12 and Hsrw in fly 
head tissue upon downregulation of U12 or Hsrw.  
 
In addition to the identified targets U12 and Hsrw , there may be other targets regulated 
by LEC and SEC that are critical in disease. In addition, in previous studies, targets of 
LEC and SEC were identified and investigated in non-neuronal cells, including 
Drosophila S2 cells 69, mouse embryonic cells73, human HCT-116 cells 72 and human 
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HEK cells 74. It is therefore unknown the extent to which the targets of LEC and SEC are 
the same in the nervous system. Given the suppression effect of LEC and SEC 
downregulation on TDP-43-mediated neurodegeneration (Figure 1), identifying the 
protein-coding and non-coding RNA targets of LEC and SEC in neurons, as well as 
revealing the targets important in neurodegenerative situations may help us understand 
the roles of LEC and SEC in the nervous system and in TDP-43 toxicity more 
thoroughly.  
 
To define the global targets of LEC and SEC in the nervous system and identify 
important genes in TDP-43 toxicity, I propose to use ChIP-seq complemented with RNA-
seq to identify genes bound by different factors and detect the transcriptomic changes 
under different conditions. ChIP-seq can be conducted using antibodies against Ell (the 
shared component), Ice1 (specific to LEC) and Lilli (specific to SEC) and TDP-43, in fly 
brains/heads with or without TDP-43 expression. Targets of LEC are predicted to be 
those bound by Ell and Ice1, while targets of SEC are predicted to be those bound by Ell 
and Lilli. Comparisons of LEC or SEC targets in TDP-43 expressing animals to controls 
are predicted to elucidate whether LEC or SEC bind to different sets of genes in the fly 
disease model compared to the normal condition. 
 
RNA-seq can be used to analyze and compare the transcriptome in fly heads or brains 
with the combination of TDP-43 expression, depletion of Ell (the shared component), 
Ice1 (specific to LEC) and Lilli (specific to SEC) (Table 3-2). By comparing Group 1 and 
2, gene alterations caused by TDP-43 expression can be identified. This analysis would 
also improve our understanding of this fly disease model. The LEC-regulated genes in 
fly brain are predicted to be downregulated in both Group 3 and 5, compared to Group 1. 
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The SEC-regulated genes will be those downregulated in Group 3 and 7 compared to 
Group 1. Important targets of LEC in disease are predicted to be those upregulated in 
Group 2 and rescued in Group 4 and 6. Likewise, potential important targets of SEC are 
those upregulated in Group 2 and decreased back toward normal in Group 4 and 8. 
Defined target genes then can be further analyzed for confirmation and functional 
importance using fly and human cell disease models. Alternatively, to reduce the 
complexity and numbers of samples, RNA-seq could be done focusing only the 
combinations of TDP-43 expression and Ell downregulation. The involvement of Ice1 
and Lilli could be assessed by ChIP-qPCR later once specific genes are identified. The 
best time point and conditions for sample collection would require determination by pilot 
studies using target genes identified in this thesis work, such as U12 and Hsrw. 
 
Table 3-2. Experimental design for identification of global LEC and SEC targets 
Group 1 2 3 4 5 6 7 8 
TDP-43  - + - + - + -  
Ell RNAi - - + + - - - - 
Ice1 RNAi - - - - + + - - 
Lilli RNAi - - - - - - + + 
 
 
Does Ell, U12 or Hsrw affect stress sensitivity? 
TDP-43 expressing flies show hypersensitivity to heat stress, paraquat-induced oxidative 
stress and starvation 103. In my thesis, we show that the heat shock-induced lncRNA 
Hsrw is aberrantly upregulated in fly heads with TDP-43 expression. These data suggest 
that the stress response may be misregulated in these animals. Environmental stress 
can be broadly defined as environmental changes that threaten or disrupt physiological 
homeostasis and reduce the performance or fitness of the organism 149,150. The effect of 
stress on an organism depends on the type of stressor, the stress intensity and duration, 
 
 
93 
and different situations may trigger different stress responses 151. Therefore, it is likely 
that TDP-43 expressing animals may react differently according to the specific stress 
situation 151,152. 
 
A question we have is whether the suppression effect of depletion of Ell, U12 or Hsrw on 
TDP-43-mediated degeneration is through modulating the stress response. To test this 
hypothesis, one can start from assessing sensitivity of flies to a variety of stress 
situations with TDP-43 expression combined with downregulation of Ell, U12 and Hsrw. 
The prediction is that expression of TDP-43 may lead to altered sensitivity to different 
stressors and stress situations, and depletion of Ell, U12 and may rescue the affected 
stress sensitivity.  
 
Is transcriptional pausing regulation affected? 
Misregulation of transcriptional elongation has been associated with different diseases, 
including cancer, virus infection and developmental diseases 79,82,123. Yet very little was 
known about its involvement in neurodegenerative diseases prior to this work. Our study 
suggests a model of abnormal activation of LEC and SEC in TDP-43-mediated 
neurodegeneration (Figure 2-7). This predicts that transcription pausing regulated by 
LEC and SEC is misregulated. This idea is supported by our data showing targets of 
LEC and SEC are upregulated in the disease models (Figure 2-2 and 2-4). However, to 
further strengthen and prove this hypothesis, direct evidence of dysfunction of 
transcriptional pausing regulation is required.  
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The regulation of transcription elongation in TDP-43-mediated degeneration can be 
assessed for specific targets or investigated globally by different assays in the disease 
models used in this study. The stress-induced lncRNA Hsrw regulated by SEC is defined 
as a novel target of TDP-43 (Figure 2-3 and 2-4), and this specific gene can be an 
interesting target for accessing pausing regulation. I propose to use ChIP-qPCR with 
antibody against total Pol II and qPCR primers to detect Pol II occupancy on Hsrw gene 
at either the transcriptional start site (~0), pausing region (~+30) or intergenic regions as 
a control. A second method, permanganate (KMnO4) footprinting, can also be used to 
assess pausing regulation on Hsrw. Paused and transcriptionally engaged Pol II leads to 
single-stranded DNA regions, where potassium permanganate can oxidize thymines. 
The oxidized thymines can then be cleaved, and the positions of DNA breaks can be 
determined by ligation-mediated PCR (LM-PCR) using primers specific to Hsrw.  
 
The genome-wide identification of pausing regulation in TDP-43 disease models can be 
assessed by precision nuclear run-on sequencing (PRO-seq) 153 by using 1) nuclei 
isolated from fly heads with or without TDP-43 expression 2) nuclei isolated from HEK 
cells with GFP-TDP-43 expression or GFP expression. In PRO-seq, isolated nuclei are 
treated with Sarkosyl, which prevents new incorporation of Pol II into the chromosomes, 
and used for identification of sites with transcriptional-engaged Pol II by extending 
nascent RNAs with biotin-labeled ribonucleotide triphosphate analogs (biotin-NTP). By 
comparing the Pol II active sites in the fly and human cells with TDP-43 expression to 
controls, any alterations to transcriptional pausing regulation on coding and non-coding 
genes can be revealed. 
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Ell as a universal therapeutic target 
in neurodegenerative diseases? 
In ALS and FTD, another important 
disease factor is the GGGGCC (G4C2) 
hexanucleotide repeat expansion. 
Over the last 7 years, a G4C2 
hexanucleotide repeat expansion in 
the 5’ region of C9ORF72 has been 
identified as the most common 
genetic mutation in ALS and FTD 130,131. Expression of transgenes bearing a G4C2 
hexanucleotide repeat expansion in the fly causes neurodegeneration 147,154-156. In our 
study, Ell was identified as a strong dose-dependent modifier of TDP-43 toxicity (Figure 
2-1). Given that ALS and FTD are within the same disease spectrum and share 
molecular features, we tested the effect of Ell downregulation on fly eye degeneration 
caused by expression of G4C2 hexanucleotide repeat expansion. The results show that 
Ell depletion also markedly ameliorates toxicity of G4C2 hexanucleotide repeat expansion 
(Figure 2-S9). In additional preliminary results, the suppression effect of Ell 
downregulation on G4C2 hexanucleotide repeat expansion toxicity in a lifespan assay 
was also observed, by using the drug-inducible ubiquitous daGS promoter (Figure 3-2). 
Although a modest effect, the impact on lifespan is rigorous when compared with 
controls (Figure 3-2). These data suggest that shared targets of Ell might be critical to 
degeneration associated with these two disease factors. 
 
Moreover, my data indicate that different neurodegenerative diseases beyond ALS and 
FTD might share similar pathways. Neurodegenerative diseases accord common 
Figure 3-2. Ell depletion suppresses the 
toxicity of G4C2 expansion 
Lifespan assay show that Ell depletion extends 
the lifespan of flies with G4C2 repeat expression. 
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pathogenetic mechanisms involving aggregation of misfolded proteins, as with Tau and 
Amyloid-beta (Aβ) in Alzheimer’s disease, α-Synuclein in Parkinson’s disease, 
Huntingtin in Huntington and TAR DNA binding protein 43 (TDP-43) in ALS and FTLD-
TDP 157,158. Although the type of disease proteins and the cellular and regional 
distribution of aggregates are varied among the diseases, similar biological and genetic 
pathways may link these disorders. To assess the involvement of Ell in other 
neurodegenerative diseases associated with additional toxic proteins, the effect of Ell 
downregulation was examined in fly disease models expressing Tau and Aβ in the fly 
eye. Expression of Tau and Aβ driven by the eye specific driver gmr led to eye 
degeneration that was be suppressed by Ell depletion (Figure 3-3).  
 
 
 
These preliminary data suggest that Ell might be a central factor among a range of 
different toxicities associated with different neurodegenerative proteins. To identify the 
common and distinct coding and noncoding targets of Ell in different disease models 
may provide effective therapeutic insight. Before further addressing the potential central 
Figure 3-3. Depletion of Ell suppressed the toxicity of Tau and Aβ 
External eye images show that expression of Tau and Aβ cause eye 
degeneration, which are ameliorated by Ell downregulation. 
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role of Ell in neurodegeneration, one should clarify whether the suppression effects of Ell 
are through decreasing the levels of the disease factors. The reason for this is that Ell 
might play different roles in mechanisms associated with different disease factors. For 
example, depletion of a transcriptional elongation factor Spt4 has been shown to 
decrease the transcripts of expanded G4C2 repeats 159. Potentially, downregulation of Ell, 
which is also involved in the regulation of elongation, could also affect the production of 
G4C2 repeat transcripts and therefore suppress the toxicity associated with the repeat 
expansion. 
 
Next, to identify the important targets of Ell in different disease models, I propose to test 
the toxicity of disease factors and the suppression effect of Ell carefully by the drug-
inducible ubiquitous driver daGS using lifespan and other assays. RNA-seq can then be 
used to compare the transcriptomes in fly heads/brains with the combination of 
expression of different disease factors and Ell RNAi (Table 3-3). Transcriptome changes 
in different disease models can be identified by comparing Group 2, 5 or 7 to Group 1. 
Important Ell targets that are common in all disease models are predicted to be 
upregulated in Group 2, 5, and 7 and downregulated in Group 4, 6 and 8. Furthermore, 
critical Ell targets that are specific for each disease factor can also be identified by 
comparing changes among the different groups. To reduce complexity, it may be 
impactful to start from TDP-43 and G4C2 hexanucleotide repeat expansion, which are 
two distinct factors but important for the same disease spectrum of ALS/FTD. 
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Table 3-3. Experimental design for identification of common and distinct Ell 
targets 
Group 1 2 3 4 5 6 7 8 
TDP-43  - + - + - - - - 
G4C2  - - - - + + - - 
Tau or Aβ - - - - - - + + 
Ell RNAi - - + + - + - + 
 
Can Sat III affect TDP-43 LLPS or aggregation? 
Our work identified the Drosophila stress-induced lncRNA Hsrw, which is upregulated in 
a fly disease model, as a novel modifier of TDP-43-mediated degeneration (Figure 2-3, 
2-4). Furthermore, human orthologue Sat III repeats are abnormally elevated in a human 
cellular model and frontal cortical tissue from FTD patients with TDP-43 pathology 
(Figure 2-5). One question is how elevated Sat III may contribute to TDP-43-mediated 
toxicity. TDP-43, containing a low complexity domain, forms aggregates in neurons and 
glia of ALS and FTLD-TDP patients 9,10, and purified TDP-43 can undergo liquid liquid 
phase separation (LLPS) and form aggregates in vitro 160,161. Many of the disease-
associated TDP-43 mutations promote TDP-43 aggregation in disease models, 
suggesting formation of inclusions may be causal to the TDP-43-associated 
dysfunction162,163.  
  
Distinct from other stress genes, the Sat III RNAs form a transient subnuclear organelle, 
the nuclear stress body (nSB), which is associated with the site of Sat III DNA; the 
comparable structure in Drosophila is the omega speckle 106,108,109. Our data show that 
TDP-43 localizes to the Hsrw locus (Figure 2-3), suggesting that TDP-43 may also bind 
the w speckle. In fact, TDP-43 has been reported to localize to nSB under heat shock in 
HeLa cells 164, suggesting that Sat III may interact with TDP-43. Thus, it may be that 
highly repetitive Sat III RNAs increase the local concentration of various RNA-binding 
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proteins, including TDP-43, and promote LLPS to form nSB. These data lead us to 
hypothesize that there might exist a feedback loop between TDP-43 and Sat III: in 
disease, TDP-43 expression leads to the elevation of Sat III levels, which in turn 
contributes to TDP-43-mediated toxicity by promoting TDP-43 LLPS and/or aggregation, 
potentially in the nSB. 
 
LLPS has been proposed to be a dynamic process that gives rise to membrane-less 
organelles 165,166, and RNAs have been shown to regulate LLPS 167-169. As one test of this 
hypothesis, Sat III generated by in vitro transcription can be added to TDP-43, and LLPS 
and aggregation can be measured using different concentrations of RNA and protein to 
assess whether Sat III can alter TDP-43 droplet formation or aggregation. Sat III by itself 
can also be tested for LLPS. These in vitro assays can test the hypothesis and might 
provide more mechanistic insights for the findings from the in vivo studies. 
 
Conclusion 
Our studies have defined a critical role for ELL in toxicity of TDP-43.  Importantly, the 
ELL regulated pathway may be broad, and the future directions proposed seek to define 
those pathways in greater detail, as well as define the specific mechanisms of the 
pathways revealed in this thesis with greater clarity.  
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